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SUMMARY
Since the generation of cell-type specific knockout models, the importance of inter-cellular communi-
cation between neural, vascular, andmicroglial cells during neural development has been increasingly
appreciated. However, the extent of communication between these major cell populations remains to
be systematically mapped. Here, we describe EMBRACE (embryonic brain cell extraction using FACS),
a method to simultaneously isolate neural, mural, endothelial, and microglial cells to more than 94%
purity in 4 h. Utilizing EMBRACE we isolate, transcriptionally analyze, and build a cell-cell communi-
cation map of the developing mouse brain. We identify 1,710 unique ligand-receptor interactions be-
tween neural, endothelial, mural, and microglial cells in silico and experimentally confirm the APOE-
LDLR, APOE-LRP1, VTN-KDR, and LAMA4-ITGB1 interactions in the E14.5 brain. We provide our
data via the searchable ‘‘Brain interactome explorer’’, available at https://mpi-ie.shinyapps.io/
braininteractomeexplorer/. Together, this study provides a comprehensive map that reveals the rich-
ness of communication within the developing brain.
INTRODUCTION
Embryonic development is a highly reproducible process that requires extensive communication between
cells. Inter-cellular communication is particularly evident during the development and maturation of the
mammalian brain. During embryonic development, human and murine brains consist primarily of neural
stem cells that give rise to progenitors, whichmigrate into the developing cortex and differentiate into neu-
rons (Jiang and Nardelli, 2016). In contrast, astrocytes and oligodendrocytes start to develop around the
time of birth and are largely absent during prenatal development. In addition to the neural lineage, micro-
glia, the resident immune cells of the central nervous system, as well as vascular endothelial cells and peri-
cytes are also present in the developing brain (Alliot et al., 1999; Daneman et al., 2010b; Vasudevan et al.,
2008). The presence and functionality of vascular cells and microglia is critical for proper neural develop-
ment, and dysregulation of these cells results in severe neural disorders (Daneman et al., 2010b; Matco-
vitch-Natan et al., 2016; Mathys et al., 2017; Sengillo et al., 2013; Vasudevan et al., 2008). Indeed, neural
cells not only communicate to impart particular cell fates upon each other (Barnabe-Heider et al., 2005;
Yuzwa et al., 2016), but also communicate with developing vascular cells andmicroglia to guide their devel-
opment (Haigh et al., 2003; Ma et al., 2017; Nikolakopoulou et al., 2013; Sellner et al., 2016). For instance,
VEGF-A released by neural progenitor cells is detected by endothelial cells and is critical for proper angio-
genesis and vascularization of the developing brain (Haigh et al., 2003). Similarly, endothelial cells are able
to modulate the behavior of neural stem and progenitor cells (Crouch et al., 2015), as well as recruit vascular
pericytes to ensure proper establishment of the blood-brain barrier (Hellstrom et al., 1999; Winkler et al.,
2010). Simultaneously, pericytes provide differentiation signals for endothelial cells and modulate their
function (Daneman et al., 2010b). Furthermore, microglia begin to enter the developing brain around E9
(Alliot et al., 1999; Stremmel et al., 2018) and modulate aspects of neural differentiation and synaptic struc-
ture (Nikolakopoulou et al., 2013; Paolicelli et al., 2011; Zhan et al., 2014). Despite the accumulation of ev-
idence that interactions between neural cells, microglia, and vascular cells are critical for proper brain
development, the identity of the molecules that mediate these inter-cellular interactions remains to be sys-
tematically mapped.
Fluorescence-activated cell sorting (FACS) is commonly used for the isolation and profiling of neural
vascular cells andmicroglia. Microglia can be enriched using antibodies against CD11b and CD45 (Bennett
et al., 2016; Datta et al., 2018; Mathys et al., 2017), whereas isolation of the mural cell population, which
spans both pericytes and smooth muscle cells, typically relies on transgenic mice expressing fluorescent
proteins under the Pdgfrb and Cspg4 promoters (He et al., 2016; Vanlandewijck et al., 2018). Similarly,
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studies have utilized transgenic approaches such as Tie2-GFP (Daneman et al., 2010a; Zhang et al., 2014)
and Cldn5-GFP (Vanlandewijck et al., 2018) animals for the isolation of endothelial cells. Given the time-
consuming nature of transgenic animal production and crossing to mouse models of interest, researchers
have been attempting to establish antibody-based methods for the isolation of vascular cells. Antibodies
against CD13 (Crouch and Doetsch, 2018) and PDGFRb (Epshtein et al., 2017) have recently been tested for
the isolation of mural cells, whereas the use of antibodies against CD31 (PECAM1) is becoming more wide-
spread for the isolation of endothelial cells (Crouch and Doetsch, 2018; Czupalla et al., 2018; Fan et al.,
2014; Wang et al., 2019). The specificity of these markers has been confirmed using immunohistochemistry.
However, the accuracy or purity of cell populations obtained from antibody-based FACS methods is yet to
be quantifiably tested. Furthermore, given the importance of inter-cellular communication within the brain,
a reliable and efficient method is still required to simultaneously isolate neural, vascular, and microglial
cells to map changes in inter-cellular networks in genetically modified model systems.
In the current study, we describe EMBRACE (embryonic brain cell extraction using FACS), a method that
allows for the simultaneous and rapid isolation of neural, mural, endothelial, and microglial cells from
the embryonic brain. The combinations of cell-type specific markers utilized in EMBRACE permit it to
achieve 94%–100% purity for each of the cell populations, which we validate through single cell RNA
sequencing (scRNA-seq) analyses. To capture lowly expressed genes and to obtain better transcriptional
resolution for in-depth analyses, we additionally perform low-input bulk RNA-seq on cell populations iso-
lated by EMBRACE. Utilizing this transcriptomic data, we build a cell-cell communication network that re-
veals the richness and extent of communication within the developing brain.
RESULTS
Sorting Strategy for the Isolation of Neural, Microglial, and Vascular Cells
In the current study, we set out to establish a protocol for the simultaneous isolation of neural, mural, endo-
thelial, and microglial cells and systematically map interactions between these four cell types. We chose to
focus our efforts on the E14.5 mouse brain for these analyses. The neural population in the E14.5 embryo
consists primarily of neural stem and progenitors cells as well as migrating neurons (Jiang and Nardelli,
2016). Thus, cell dissociation methods are unlikely to cause excessive cell death as is common with mature
neuronal populations, which possess extensive neurites. Furthermore, microglial seeding of the brain be-
gins around E9 and is completed by E14.5 (Stremmel et al., 2018), suggesting that microglia would already
be present and likely interacting with their native neural environment in the E14.5 brain. Neural vasculari-
zation and angiogenesis are also evident at E14.5 with the presence of maturing endothelial cells, active
migration of tip cells, as well as recruitment and differentiation of mural cells (Tata et al., 2015). In fact,
blood-brain barrier (BBB) maturation is completed around E15.5, suggesting that analyses at E14.5 are
likely to reveal key factors required for BBB maturation.
To identify the most efficient method to dissociate E14.5 embryonic brains into a single cell suspension, we
tested a number of enzymatic and non-enzymatic methods. We identified the combination of Liberase and
DNase I as the most reliable method that gave the best cell viability (67.8%, Table S1). Therefore, we em-
ployed the combination of Liberase and DNase I for brain dissociation in all subsequent experiments.
To isolate the rare mural, endothelial, and microglial cell populations by FACS, we searched for cell surface
proteins that are enriched in each of the cell types and screened for specific antibodies against these
markers. We identified antibodies against PECAM1 (CD31) and CD102 that faithfully co-stained endothelial
cells, as well as CD11b and CD45 antibodies that co-stained a microglial population (Figures 1A and 1B).
We next searched for strongly expressed cell surface markers specific for the mural cell population. Utiliz-
ing a recently published single cell RNA sequencing dataset from the adult brain (Vanlandewijck et al.,
2018), we chose to focus on Pdgfrb andCspg4 as they are both cell surface proteins and strongly expressed
in all mural cells (Figures S1A–S1D). We screened antibodies against PDGFRb and CSPG4 through immu-
nofluorescence and FACS analyses and were able to identify a highly specific PDGFRb antibody that we
used in subsequent experiments (Figures 1C, 1D, and S1E–S1L).
The identity of individual cells can be determined via scRNA-seq through the analyses of cellular transcrip-
tomes (Grun and van Oudenaarden, 2015). To test the specificity of our selected markers and antibodies,
we stained E14.5 brain cells with the pre-screened antibodies, isolated them using FACS and determined
cell identity through scRNA-seq with the mCEL-Seq2 protocol (Figure 1E). We defined neural cells using a
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Figure 1. Identification of Cell Surface Markers for the Isolation of Neural, Microglial, and Vascular Cells
(A) FACS plot showing enrichment of endothelial cells using PECAM1 and CD102 (ICAM2).
(B) Exemplary FACS plot depicting the FACS strategy for the enrichment of microglia using CD11b and CD45.
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set of negative makers to ensure we were obtaining the full spectrum of neural cells present in the E14.5
brain (PECAM1neg, CD102neg, PDGFRbneg, CD45neg, CD41neg). Endothelial cells, mural cells, and microglia
were selected based on positive markers as indicated in Figures 1A, 1B, and 1D. Following scRNA-seq, we
filtered for cells with more than 1,500 transcripts, leading to the selection of 625 cells. Through unsuper-
vised clustering of sorted cells using RaceID3 (Grun et al., 2015; Herman et al., 2018), we identified four ma-
jor cell populations with 12 distinct clusters (Figure 1F). Each of the four major clusters specifically ex-
pressed markers of neural cells (Tubb3, Sox11, Dcx), mural cells (Pdgfrb, Rgs5, Anpep), endothelial cells
(Pecam1, Kdr, Cd93), or microglia (Ptprc, Itgam, C1qc) (Figure 1G). We next correlated our selected cell
surface markers to the identity of cells as determined by unsupervised clustering. We found that our selec-
tion criteria allowed us to isolate neural cells, mural cells, endothelial cells, and microglia to between 94%
and 100% purity (Figures 2A–2E). Furthermore, each of the populations strongly expressed genes known to
be important for their function (Figures 2F–2I, Tables S3–S6), whereas GO-term analyses showed significant
enrichment of terms known to functionally correlate with each cell type (Figure 2J). Together, these ana-
lyses revealed that we were able to isolate the major cells within the developing brain, namely neural cells,
mural cells, endothelial cells, and microglia, to high purity using a FACS-based strategy.
Identification of Heterogeneity in Neural, Mural, and Endothelial Cell Populations
We next wanted to examine the extent of cellular heterogeneity within each of the cell populations. To this
end, we analyzed the clusters within each of the four major cell populations. Neural, mural, and endothelial
cell populations contained three distinct clusters each, indicating heterogeneity within each cell type (Fig-
ure 1F). On the other hand, only one microglial cluster was detectable, probably because of the small num-
ber of cells sequenced (Figure 1F, cluster 5). We identified a number of characteristic genes for each sub-
population using differential gene expression analysis between the clusters (Figure S2). The greatest level
of cellular heterogeneity was observed among the three neural clusters, reflecting the number of distinct
neural stem and progenitor cells as well as distinct differentiating neurons found within the E14.5 brain (Fig-
ures S2A–S2D). Similarly, we detected three distinct cell states in the endothelial and mural cell clusters
(Figures S2E–S2J), suggesting that our cell sorting procedure was indeed able to detect and isolate a range
of neural, mural, and endothelial cell populations present in the mouse embryonic brain.
Simultaneous Isolation and Analyses of Neural, Mural, Endothelial, andMicroglial Cells Using
EMBRACE
Although scRNA-seq is an ideal tool for detecting cellular heterogeneity and phenotypic shifts in cell pop-
ulations, only the most strongly expressed transcripts are typically detected. This may hinder the ability to
detect the complete transcriptome of cells and undertake detailed analyses of functionally important lowly
expressed genes and transcription factors. For this purpose, we simultaneously collected neural cells
(CD45neg, CD41neg, CD11bneg, PECAM1neg, CD102neg, PDGFRbneg), mural cells (PDGFRbhigh, PECAM1neg,
CD102neg, CD45neg, CD41neg, CD11bneg), endothelial cells (PECAM1+, CD102+, CD45neg, CD41neg,
CD11bneg, PDGFRbneg), and microglia (CD45medium, CD11b+, PECAM1neg, PDGFRbneg) from E14.5 brain
samples by FACS using the markers that we had established (Figure 3A). We refer to this methodology
as EMBRACE. Using EMBRACE, we obtained around 5.4 million neural cells, 4,000 mural cells, 4,000 endo-
thelial cells, and 7,000microglia from each E14.5 brain (Figure 3B). We analyzed the isolated cell population
Figure 1. Continued
(C) Immunofluorescence image showing a blood vessel in the E14.5 brain stained for the mural cell marker PDGFRb (green) and endothelial marker PECAM1
(red). The PDGFRb antibody (from R+D) showed high specificity as evident by the strong peri-vascular staining. This is in contrast to other tested PDGFRb
and CSPG4 antibodies that showed unspecific staining (Figures S1H–S1L). Scale bars are provided in micrometers.
(D) Sorting strategy for PDGFRb-positive mural cells.
(E) Schematic representation of scRNA-seq procedure used to test the specificity of the neural, microglial, and vascular cell isolation procedure. E14.5 mouse
brains were dissociated using Liberase and DNase I, and the single cell suspension stained for selected cell surface markers followed by FACS of single cells
into 384-well plates. Libraries for sequencing were prepared using the mCEL-Seq2 protocol. Cells were isolated in equal numbers from three independent
wild-type E14.5 brains.
(F) The t-distributed stochastic neighbor embedding (tSNE) plot generated with the RaceID3 package (Herman et al., 2018) of the 625 cells that were isolated
using the selected cell surface markers and passed the filtering criteria (>1,500 unique transcripts). Twelve distinct clusters and four major cell populations
were identified by unsupervised clustering.
(G) Expression of neural, mural, endothelial, andmicroglial cell-type-specific genes. Each of the cell types was confined to one of themajor clusters. Note the
low levels of Cd13 expression in the mural cell population. The numbers in parenthesis represent the proportion of cells in the respective cluster where
marker expression was detectable.
See also Figures S1 and S2.
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Figure 2. High Enrichment of Neural, Mural, Endothelial, and Microglial Cells Using EMBRACE
(A–D) tSNE maps showing the clustering of cells sorted based on markers for (A) neural cells, (B) mural cells, (C) endothelial cells, and (D) microglia.
(E) Identity of cells in each of the four EMBRACE-sorted populations based on the comparison of cell surface markers and cell identity, as specified by
unsupervised hierarchical clustering of scRNA-seq data.
(F–I) Top 10 genes enriched in (F) neural, (G) mural, (H) endothelial, and (I) microglia clusters. A more comprehensive list of genes enriched in each of the cell
populations can be found in Tables S3–S6.
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transcriptomes via RNA-seq. Compared with an average of 2,439 unique genes per cell in the single-cell
RNA-seq experiments, we detected around 24,000 genes in the bulk population RNA-seq, giving us
greater power for downstream analyses (Figure 3C). These observations were consistent with other
scRNA-seq studies (Rosenberg et al., 2018; Vanlandewijck et al., 2018; Zeisel et al., 2018), which also de-
tected between 677 and 3,254 unique genes per cell (Figure S3A). The EMBRACE-isolated cell populations
were strongly enriched in their respective cell markers (Figure 3D and Tables S7–S10) and showed cell-type-
appropriate biological functions in GO-term analyses (Figure 3E), thereby confirming their expected cell
identities. Together, these analyses revealed that we could isolate highly enriched neural, mural, endothe-
lial, and microglial cell populations via EMBRACE and detect a much richer transcriptome with bulk RNA-
seq compared with scRNA-seq analyses.
Building a Cell-Cell Interaction Database
To uncover potential communication between neural, mural, endothelial, and microglial cells in the
developing mouse brain, we built an in silico cell-cell communication network via quantification of
ligand-receptor interactions between the four different cell types. We utilized the ligand-receptor pair
dataset generated by Ramilowski and co-workers to identify cell-cell interactions (Ramilowski et al.,
2015). We filtered the bulk RNA-seq data for genes that showed an average expression of greater than
10 FPKM across all four cell types. Consistent with the greater sensitivity of RNA-seq on bulk-sorted pop-
ulations, we were able to identify 20-fold more cell-cell interactions in the bulk RNA-seq dataset compared
with scRNA-seq data (Figures 4A and S3B–S3D). Indeed, our bioinformatics analyses predicted between
350 and 550 ligand-receptor interactions between each of the four different cell types with a total of
1,710 unique interactions based on the EMBRACE RNA-seq data, including extensive autocrine signaling
(Figure 4B and Table S11). We have provided access to the complete inter-cellular communication data-
base via the online ‘‘Brain interactome explorer’’ (https://mpi-ie.shinyapps.io/braininteractomeexplorer/).
We next wanted to test the accuracy of our database by interrogating the presence of well-established cell-
cell interactions that are known to occur in the developing brain. VEGF-A from neural cells is known to
induce the vascularization of the brain via angiogenesis (Haigh et al., 2003). Consistently, our analyses pre-
dicted a substantial interaction between Vegfa from neural cells with the VEGF receptor Kdr (Vegfr2) in
endothelial cells (Figure 4C). Similarly, the interaction between the angiopoietin (Angpt) ligands and Tie
receptors as well as between platelet-derived growth factors (PDGF) and PDGF receptors is critical for
proper vascular development. We could indeed map strong interactions connecting these ligand-receptor
pairs (Figures 4D and 4E). In addition, we searched for established communication modules essential for
neural cell development. We uncovered widespread WNT and Ephrin signaling centered around neural
cells (Figures S4B and S4C), consistent with the critical role of WNTs and Ephrins in neural development
(Lisabeth et al., 2013; Mulligan and Cheyette, 2012; Noelanders and Vleminckx, 2017). Together, these ex-
amples suggest that our inter-cellular communication network is able to detect important inter-cellular
communication modules known to occur in the E14.5 brain.
Having established that we could detect well-established cell-cell interactions in our dataset, we next
focused on detecting potentially novel and previously overlooked communication modules within the
developing brain. We mapped the interaction of the top 50 expressed ligand-receptor pairs, for which
the ligand expression was enriched in at least one cell population (Figures 4F and S4D). Cells with the high-
est broadcasting capacity were microglia followed bymural cells. The strongest interactions were detected
between microglia and neural cells and were underpinned by APOE signaling (Figures 4F and S4D).
Although the importance of APOE signaling and APOE allele variants in Alzheimer disease is well estab-
lished (Farrer et al., 1997; Poirier et al., 1993; Strittmatter et al., 1993), the importance of Apoe in develop-
ment is comparatively poorly understood. Our transcriptomic analysis showed high levels of Apoe
expression in microglia at E14.5 (Figure 5A). We confirmed the strong enrichment of APOE expression in
IBA1+ microglia via immunofluorescence (Figure 5B). Consistent with the fact that APOE is a secreted pro-
tein (Bu, 2009), we also observed widespread APOE signal in the E14.5 brain (Figure 5B). We next tested
Figure 2. Continued
(J) Heatmap depicting mean expression per cluster of top enriched genes in each cell population together with gene ontology analysis (biological process).
The enrichment score was calculated by determining the expression of a particular gene in a specific cell cluster relative to the mean expression of that same
gene across all cell clusters.
See also Figure S2.
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Figure 3. Population-Based Transcriptomic Analyses of Neural, Mural, Endothelial, and Microglial Cells Provide a Rich Cellular Transcriptome
(A) EMBRACE sorting strategy with representative gating for the isolation of neural cells, mural cells, endothelial cells, and microglia.
(B) Average numbers of cells recovered from each E14.5 brain. Error bars indicate meanG SEM. N = 6 E14.5 brains for neural cells and N = 11 E14.5 brains for
endothelial, mural, and microglial cells.
(C) Mean number of unique genes detected per cell and per cell type in the scRNA-seq data, as well as in EMBRACE-based bulk RNA-seq experiments. Error
bars indicate meanG SEM. N = 625 single cells isolated from three independent brains with a minimum of 1,500 unique transcripts; N = 3 wild-type brains for
bulk population-based analyses.
(D) Enrichment of neural, mural, endothelial, and microglial markers in the four EMBRACE-enriched populations. A comprehensive list of genes enriched in
each of the four populations is provided in Tables S7–S10.
(E) Gene ontology (biological processes) analyses of the top enriched genes (enrichment >10-fold) in each of the four EMBRACE-isolated cell populations—
neural, mural, endothelial, and microglial cells.
The enrichment scores in (D) and (E) were calculated by determining the expression of a particular gene in a specific cell type relative to the mean expression
of that same gene across all 4 EMBRACE-isolated cell populations.
EC - endothelial cells; Mg - microglia; Mu - mural cells; N - neural cells. See also Figure S3.
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Figure 4. Extensive Inter-Cellular Communication in the Developing Brain
(A) Number of detected ligands, receptors, and ligand-receptor pairs in the scRNA-seq dataset compared with transcriptional analyses of bulk isolated cell
populations.
(B) Map of ligand and receptor interactions between neural, mural, endothelial, and microglial cells based on transcriptomic analyses of EMBRACE-isolated
cell populations. Arrow color corresponds to the ligand source, and the numbers indicate the quantity of detected ligand-receptor pairs between the
indicated cell types. The comparable interaction map for the scRNA-seq data is provided in Figure S3B.
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whether APOE could interact with its known receptors LRP1 and LDLR in the E14.5 brain. Through immu-
nofluorescence, we found the APOE expression pattern to overlap with LRP1 and LDLR signals (Figures 5C,
5D, and S4E). In addition, immunoprecipitation of endogenous APOE was able to pull down LRP1 in lysates
of the E14.5 brain (Figure 5E), highlighting the existence of significant APOE signaling activity in the devel-
oping brain. These data suggest that microglia-expressed APOE is likely to have an important role in brain
development through its extensive signaling to embryonic neural and endothelial cells.
Mural cells showed strong expression of secreted proteins that are not well studied in the context of neural
development. The most prominent was vitronectin (Vtn), which is thought to signal via integrins as well as
KDR (Murphy and Stupack, 2010; Wang et al., 2015). Consistent with previous work (Seiffert et al., 1995), we
observed that VTN expression is confined to mural cells in the E14.5 brain (Figure 5F, left panel and S4D).
The significance of these observations is currently unknown. Nevertheless, work in human umbilical cord
vascular endothelial cells (HUVEC) has suggested that glycated VTN is able to inhibit the KDR receptor
as well as the outgrowth and migration of endothelial cells (Wang et al., 2015). Consistently, our analyses
suggest strong Vtn signaling from mural cells to Kdr in endothelial cells (Figure 5F). We were able to
confirm the endothelial-specific expression of KDR as well as the interaction between VTN and KDR in
the E14.5 brain using immunofluorescence analyses (Figures 5F and 5G). Although the importance of
this communication module in the developing brain is yet to be established, this interaction is consistent
with the role of mural cells in controlling aspects of endothelial cell development.
Mural cells also strongly expressed pleiotrophin (Ptn), a peptide showing high expression during develop-
ment and in diseased states (Li et al., 1990; Poulsen et al., 2000; Takeda et al., 1995; Yeh et al., 1998). PTN
can signal through a multitude of receptors, including integrins, N-syndecan, and receptor protein tyrosine
phosphatases (PTPR) (Gonzalez-Castillo et al., 2014). In neural injury models, PTN is strongly upregulated
and acts in a neuro-protective manner while promoting outgrowth of neurites (Mi et al., 2007). The precise
contribution of PTN during the developmental time frame remains unknown. However, it is likely to play an
important role given that Ptn knockout animals display neurological symptoms including increased anxiety,
reduced social interaction, and a reduction in layer IV of the cortex (Krellman et al., 2014).
The most prominent ligands expressed by endothelial cells were non-canonical ligands of extracellular ma-
trix proteins, including collagens and laminin subunit A4 (Lama4), which act primarily on endothelial cells as
well as mural cells (Figure 4F). LAMA4 is found in the extracellular matrix surrounding endothelial cells and
binds to integrin b1 (ITGB1) (Gonzalez et al., 2002). In the context of the E14.5 brain, Itgb1 displayed the
highest expression in mural cells, whereas LAMA4 was most strongly expressed in endothelial cells (Fig-
ure 5H). We found a strong overlap between LAMA4 and ITGb1 protein expression in immunofluorescence
stainings (Figure 5I). Although Lama4 deletion is known to cause defects in angiogenesis (Stenzel et al.,
2011), the importance of the cross talk between endothelial LAMA4 and mural cell ITGB1 during neural
vasculature development remains unclear.
Together, these examples highlight the versatility of our approach in facilitating the identification of poten-
tially new and under-appreciated inter-cellular communication modules within the developing brain.
DISCUSSION
In the current study, we set out to establish a method for the simultaneous isolation of neural, mural, endo-
thelial, and microglial cells and subsequently apply this method to map the cell-cell communication net-
works that exist in the developing mouse brain. We show here that we could enrich each of the four cell
Figure 4. Continued
(C) Interaction map of the KDR (VEGFR2, FLK1) receptor network. Expression of Kdr is confined to endothelial cells, whereas its ligands are expressed by
neural, mural, and endothelial cells. The heatmap represents the enrichment of gene expression in the four different cell types.
(D) Interaction map and associated heatmap for the ligand ANGPT1 (Angiopoietin).Angpt1 is expressed only in mural cells and has corresponding receptors
in microglia and endothelial cells.
(E) Interaction map and corresponding heatmap of the PDGFRb receptor network.
(F) Top 50 strongest predicted interactions between neural, mural, endothelial, and microglia cells. This list was generated by ranking the absolute
expression levels of ligand-receptor pairs across the four cell types and filtering for ligands showing cell-type specific expression. The associated heatmap is
provided in Figure S4D.
The enrichment score was calculated by determining the expression of a particular gene in a specific cell type relative to the mean expression of that same
gene across all four EMBRACE-isolated cell populations. EC – endothelial cells, Mg – microglia, Mu – mural cells, N – neural cells. See also Figures S3 and S4.
iScience 21, 273–287, November 22, 2019 281
282 iScience 21, 273–287, November 22, 2019
populations to more than 94% purity using EMBRACE. Undertaking a direct comparison of single cell and
bulk FACS-purified transcriptomes, we show that around 20-foldmore ligand-receptor pairs are detectable
in the bulk FACS-purified populations. Using an in silico approach, we map the cell-cell communication
networks and chart the E14.5 brain interactome, revealing extensive communication between neural,
mural, endothelial, and microglial cells. We experimentally confirmed selected interactions from the top
50 list, including APOE-LRP1, APOE-LDLR, VTN-KDR, and LAMA4-ITGb1, emphasizing the biological rele-
vance of our database.
Since cells in vivo are present in a complex environment, it is important to study gene function in specific
cell types in the context of the whole organ or even the organism. Using single cell or nucleus RNA-seq
analysis, inter-cellular communication databases have been generated for the heart (Skelly et al., 2018), kid-
ney (Wu et al., 2019), liver organoids (Camp et al., 2017), as well as tumors isolated from mouse models
(Kumar et al., 2018) and human patients (Puram et al., 2017; Zhou et al., 2017). Although single cell RNA-
seq is powerful in the identification of rare cell types and detection of heterogeneity between similar
cell populations, bulk RNA-seq analyses on cell populations provides a much richer transcriptome. Thus,
using a combination of both scRNA-seq and bulk population-based RNA-seq provides a much more
comprehensive picture of cell function compared with either technique alone. The disadvantage of a pop-
ulation-based RNA-seq approach is the time-consuming task of identifying and verifying cell-type specific
markers that are critical for the isolation of near-pure cell populations. In contrast, cell identity can be retro-
spectively assigned in scRNA-seq datasets based on the cellular transcriptome. However, not all genomic
techniques are currently amenable to single cell technologies and require the isolation of larger cell pop-
ulations. To this end, we have established EMBRACE, a method to simultaneously isolate neural, mural,
endothelial, and microglial cells to high purity. This sorting methodology will be particularly useful to re-
searchers conducting experiments that are not yet compatible with single cell analyses, such as 3D chro-
matin conformation capture or chromatin immunoprecipitation (ChIP). Furthermore, given the simplicity
of EMBRACE, it can easily be applied to study cell-cell communication in cell-type specific knockout mouse
models.
In contrast to EMBRACE, more complex techniques have been applied to isolate different cell types from
the adult mouse brain. Through immunopanning, transgenic animal models, as well as FACS, Zhang and
co-workers have enriched and transcriptionally analyzed endothelial cells, microglia, progenitor and
mature oligodendrocytes, neurons, and astrocytes (Zhang et al., 2014, 2016) and reported significant dif-
ferences in transcriptional splicing between these cell types (Zhang et al., 2014). Although it is difficult to
ascertain whether all cellular subtypes survive the purification procedure, these datasets nevertheless pro-
vide an excellent resource for exploring the transcriptional complexity of cell types in the adult brain. In
Figure 5. Confirmation of Inter-Cellular Signaling Modules
(A) Interaction map of the apolipoprotein E (APOE) network. Apoe is strongly expressed in microglia, whereas its receptors are primarily enriched in
endothelial and neural cells. The heatmap displays enrichment in gene expression of Apoe and its receptors in the different cell populations. Red lines
indicate the predicted APOE–LDLR and the APOE–LRP1 interactions that were experimentally tested.
(B) Enrichment of APOE protein expression in IBA1-positive microglia in the E14.5 brain. Scale bars are 20 mm in the first three panels and 5 mm in the zoom
panel.
(C) Immunofluorescence imaging showing overlap of APOE (red) and LRP1 (green) proteins in the E14.5 brain. Scale bars represent 20 mm in the first three
panels and 5 mm in the zoom panel.
(D) Immunofluorescence showing overlap of APOE (red) and LDLR (green) proteins in sections of the E14.5 brain. Scale bars represent 20 mm in the first three
panels and 5 mm in the zoom panel.
(E) Co-immunoprecipitation assay showing direct protein interaction between APOE and LRP1. APOE was immunoprecipitated from E14.5 brain lysates and
the IP material was subsequently probed with APOE and LRP1 antibodies via western blot analysis.
(F) Diagram showing the expected interaction between VTN and KDR. The full KDR interaction network is provided in Figure 4C. The immunofluorescence
images show the expected enrichment of KDR protein expression in PECAM1-positive endothelial cells. Scale bars indicate 20 mm.
(G) Immunofluorescence imaging of E14.5 brain sections showing overlap between vitronectin (VTN, green) and KDR (red) protein expression. Scale bars
indicate 10 mm in the first three panels and 5 mm in the zoom image.
(H) Interaction map and corresponding heatmap of the LAMA4 network. The LAMA4 and ITGB1 interaction, highlighted in red, was tested by
immunofluorescence analyses.
(I) Immunofluorescence images showing overlap between LAMA4 (green) and ITGb1 (red) proteins in the E14.5 brain. Scale bars indicate 20 mm in the first
three panels and 5 mm in the zoom image.
The enrichment score was calculated by determining the expression of a particular gene in a specific cell type relative to the mean expression of that same
gene across all four EMBRACE-isolated cell populations.
EC - endothelial cells; IP - immunoprecipitation; Mg - microglia; Mu - mural cells; N - neural cells; WB - western blot. See also Figure S4.
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contrast, we have focused here on the embryonic brain to determine inter-cellular communicationmodules
that are likely important for neural development. We identified a total of 1,710 interactions, many of which
are likely to play an important role during development (Figure 4B and Table S11, https://mpi-ie.shinyapps.
io/braininteractomeexplorer/).
Among the strongest interactions, we found microglia-expressed Apoe to mediate communication with
neural, endothelial, and mural cells in the E14.5 brain (Figures 4F and 5A–5E). APOE is highly abundant in
the brain and is involved in lipid transport, clearance of lipoproteins, and cholesterol homeostasis
(Hauser et al., 2011; Huang and Mahley, 2014). Apoe knockout mice kept on a high-fat diet show signif-
icant accumulation of lipids in the brain (Walker et al., 1997). At least in mouse models, APOE cannot
cross the BBB (Liu et al., 2012) and must therefore be produced locally. Our analyses show that microglia
are the major producers of APOE in the E14.5 brain (Figures 5A and 5B). There are some indications that
APOE may be important in brain development. The APOE e4 allele variant is the best-known genetic risk
factor associated with Alzheimer disease (Farrer et al., 1997; Poirier et al., 1993; Strittmatter et al., 1993),
and infants carrying this variant show delayed myelination and gray matter development in brain regions
typically affected by Alzheimer disease (Dean et al., 2014). In addition to extensive signaling between
microglia-derived APOE and neural cells, our analyses revealed interactions between APOE and its re-
ported receptors in vascular cells (Figure 4F). These interactions are also likely to be important during
development, as mice lacking Apoe display increased permeability of neural vasculature but not of ves-
sels from other organs (Hafezi-Moghadam et al., 2007; Methia et al., 2001). It is currently unknown which
molecular mechanisms drive this specific defect in neural vasculature and how Apoe deficiency impacts
neural vascular function. Together with our cell-cell interactome, these studies highlight the potential
importance of APOE during the developmental time frame and encourage the investigation of APOE
during early brain development. In addition to APOE, our dataset provides a resource of 1,710 total in-
ter-cellular interactions that are likely to play important roles during the neural developmental time
frame.
In summary, we describe here EMBRACE, a method to simultaneously isolate neural, mural, endothelial,
and microglial cells to high purity. This simple method will allow researchers to explore inter-cellular inter-
actions in their mouse models of choice. Using EMBRACE, we isolated, transcriptionally analyzed, and built
an inter-cellular communication network in the E14.5 brain that revealed 1,710 unique ligand-receptor re-
lationships (https://mpi-ie.shinyapps.io/braininteractomeexplorer/). Our dataset and brain communica-
tion network underline the richness of inter-cellular communication present in the developing brain and
provide a comprehensive resource that will allow the field to dissect the importance of selected receptors
and ligands in the context of neural development.
Limitations of the Study
In the current study, we establish the EMBRACE methodology that we use to analyze inter-cellular commu-
nication in the developing mouse brain. Given the complexity of adult brains, which consist of extensive
neural processes that are prone to damage during dissociation, the EMBRACE procedure may not be suc-
cessful in isolating neural cells from the adult brain. However, EMBRACE is still likely to be efficient in
isolating endothelial, mural, and microglial cells from the adult brain, as they express the same cell surface
markers as their embryonic counterparts and are resistant to harsh dissociation regimens.
Using the EMBRACE technique, we isolated neural, mural, endothelial, and microglial cells from the E14.5
brain and built an inter-cellular interactome based on the transcriptional profiles of each cell type. Our
database is built on gene expression levels in neural, mural, endothelial, andmural cells and uses a collated
list of ligand-receptor interactions (Ramilowski et al., 2015), which is based on diverse cell types. Thus, it will
be prudent for researchers to experimentally confirm their interactions of interest in a similar fashion as we
have done for APOE-LDLR, APOE-LRP1, VTN-KDR, and LAMA4-ITGb1 in the E14.5 brain.
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.
DATA AND CODE AVAILABILITY
The Brain Interactome Explorer is available at https://mpi-ie.shinyapps.io/braininteractomeexplorer/.
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Raw sequencing data have been uploaded to GEO and are available under GSE133079.
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Figure S1 
Screening for potential mural cell markers and antibodies. 
Related to Figure 1 
(A-D) Expression of potential mural cell markers in the published scRNA-seq database by the 
Betscholtz laboratory (Vanlandewijck et al., 2018). (A) Pdgfrb showed consistently high expression in 
all pericytes and smooth muscle cells. PDGFRβ is expressed on the cell surface making it ideal for 
downstream use. (B) Anpep (Cd13) showed weak expression that was undetectable in some 
pericytes. While this may be due to the low sensitivity of scRNA-seq, it also suggests that CD13 
expression may be heterogeneous within the mural cell population resulting in some pericytes and 
 smooth muscle cells remaining undetected. (C) Cspg4 displayed strong expression in pericytes and 
smooth muscle cells and thus was shortlisted for downstream testing. (D) While Rgs4 showed strong 
expression in pericytes and smooth muscle cells, it is an intracellular marker and thus not conducive to 
FACS. (E) Flow cytometry plot comparing the expression of PDGFRβ (R+D antibody) and the 
microglia-specific marker CD11b. PDGFRβ (R+D) antibody did not show any cross reactivity with 
CD11b. (F) Flow cytometry plot showing no overlap in staining with the PDGFRβ (R+D) antibody and 
the microglia and hematopoietic marker CD45. (G) Immunofluorescence staining using the PDGFRβ 
(R+D) antibody showing clear peri-vascular staining (white arrows) in the E14.5 brain cortex. Also see 
Figure 1C. (H-I) Flow cytometry plot showing cross-reactivity between the Becton Dickinson (BD) 
PDGFRβ antibody and microglial markers (H) CD45 and (I) CD11b. (J) Immunofluorescence staining 
using the PDGFRβ (BD) antibody showing unexpected intracellular staining in vascular cells as well as 
widespread background signal outside of the vasculature (marked by red arrows). (K-L) Flow 
cytometry plot showing cross-reactivity between the Becton Dickinson (BD) CSPG4 antibody and 
microglial markers (K) CD45 and (L) CD11b.  
Based on these analyses, the BD PDGFRβ and CSPG4 antibodies were not used and all experiments 
utilised the PDGFRβ antibody from R+D. 
N = 3 to 10 replicates per experiment in E-L. 
 
 
  
  
Figure S2 
Comparison between subpopulations of neural cells, mural cells and endothelial cells. 
Related to Figures 1 and 2 
(A) An unbiased t-distributed stochastic neighbour embedding (tSNE) plot of all sorted cells, 
regardless of the cell surface marker used for their isolation, depicting 12 total clusters encompassing 
the four major cell populations: neural cells (clusters 6 to 8), mural cells (clusters 1, 2 and 4) 
endothelial cells (clusters 3, 9 and 10) and microglia (cluster 5). While each of the neural, mural and 
endothelial populations could be split into 3 three sub-clusters, only one cluster for microglia was 
evident. (B) Heatmap depicting differential gene expression between the three main sub-populations 
of the neural population. The log2(normalised counts) value is provided for the top differentially 
expressed genes that display an enrichment score of more than 1. (C) tSNE plot showing Neurod2 
mRNA enrichment in differentiating neurons (cluster 8) compared to the stem / progenitor stem cell 
population (cluster 6). (D) tSNE plot showing enrichment of Nnat in cluster 6. (E) Heatmap depicting 
differential gene expression between the three sub-populations of mural cells isolated based on 
 PDGFRβ expression. The log2(normalised counts) value is provided for the top differentially expressed 
genes that display an absolute enrichment score of more than 0.6. (F) tSNE plot displaying expression 
of Mmp9, which is enriched in clusters 1 and 4, while lowly expressed in cluster 2. (G) tSNE plot of 
Igf2 expression. Igf2 shows strongest expression in cluster 4 and is significantly lower in clusters 1 
and 2. (H) Heatmap depicting differential gene expression between the sub-populations of endothelial 
cells isolated based on PECAM1 and CD102 expression. The log2(normalised counts) value is 
provided for the top differentially expressed genes that display an absolute enrichment score of more 
than 1. (I) tSNE plot showing Malat1 expression. While Malat1 is widely expressed, it shows the 
highest gene expression in cluster 3 of endothelial cells. (J) tSNE plot showing gradient of Spock2 
gene expression.  
The enrichment score was calculated by determining the expression of a particular gene in the given 
cell cluster relative to the mean expression of that same gene across all clusters.  
 
 
 
 
  
Figure S3 
Cell-cell communication networks between neural, mural, endothelial and microglial cell clusters 
detected in the scRNA-seq dataset. 
Related to Figures 3 and 4 
(A) Comparison of the number of unique genes detected in scRNA-seq datasets. The GSE98816 
dataset is associated with (Vanlandewijck et al., 2018), the SRP135960 dataset with (Zeisel et al., 
 2018) and the GSE110823 dataset with (Rosenberg et al., 2018). * indicate the mean number of 
genes detected per cell, while ^ represents the median number of genes detected per cell. Note that at 
greater, saturated sequencing depth (>500,000 reads per cell), Rosenberg et al. (2018) report a mean 
of 4497 detected genes per NIH/3T3 cell and 2055 genes per brain nucleus. (B) Inter-cellular 
interaction network of ligands and receptors between the 10 major clusters identified from the scRNA-
seq data. A total of 80 ligands and 61 receptors were expressed in at least one cell cluster without 
taking into consideration the existence of the complete pair. 61 pairs encompassing 40 ligands and 27 
receptors were detected in the whole database. The ligand – receptor interactions were based on the 
dataset curated by (Ramilowski et al., 2015). The thickness of lines connecting the respective clusters 
indicates the number of ligand – receptor interactions between the clusters. The size of the cluster 
circle represents the number of cells identified in the particular cluster. (C) Heatmaps showing the 
enrichment of ligands and receptors in each cluster of the scRNA-seq data as well as in bulk 
EMBRACE-isolated populations. Lines connecting ligand and receptor pairs depict the interaction 
between them. 
The enrichment score was calculated for scRNA-seq data by determining the expression of a 
particular gene in the given cell cluster relative to the mean expression of that same gene across all 
clusters. For bulk RNA-seq analyses, the enrichment score was quantified by determining the 
expression of a particular gene in a specific cell type relative to the mean expression of that same 
gene across all 4 EMBRACE-isolated cell populations.  
EC – endothelial cells, Mg – microglia, Mu – mural cells, N – neural cells 
 
 
 
 
 
 
  
 
Figure S4 
Key communication networks in neural, mural, endothelial and microglial cell populations 
Related to Figures 4 and 5 
(A) Enrichment of cell type markers in the scRNA-seq dataset for each cell type. (B) Interaction ligand 
- receptor map for WNT signaling based on transcriptomic analyses on bulk sorted populations. Note 
the high number of interactions involving neural cells. (C) Interaction map for Ephrin A1 (Efna1), which 
is highly enriched in endothelial cells, and its receptors, which are primarily expressed in neural cells. 
The heatmap displays enrichment in gene expression of Ephrin A1 and its receptors in the different 
 cell populations based on the enrichment score. (D) Heatmap based on the interaction map provided 
in Figure 4F. The heatmap displays gene expression of the 50 highest scoring ligand-receptor pairs 
bioinformatically mapped in the developing brain. The enrichment of each ligand and receptor is 
shown based on the enrichment score in neural, mural, endothelial and microglial cells. (E) 
Immunofluorescence images showing widespread expression of LDLR, especially in βIII-tubulin 
positive neurons in the E14.5 brain. Scale bars indicate 20 µm.   
The enrichment score was calculated by determining the expression of a particular gene in a specific 
cell type relative to the mean expression of that same gene across all 4 EMBRACE-isolated cell 
populations.  
EC – endothelial cells, Mg – microglia, Mu – mural cells, N – neural cells 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
Table S1 
Related to Figure 1 
Comparison of methods used for the dissociation of E14.5 brains. The scale spans “-” not detected, to 
“++++” present at highest levels. “Clumpiness” and “Digestion” were determined by the fraction of cells 
failing to pass through a 100 µm filter after digestion. Ease of digestion was determined by the amount 
of manual pipetting required to dissociate the tissue until no obvious tissue clumps were visible. 
 
 No enzyme 
Collagenase 
Dispase 
Pancreatin 
Trypsin 
Liberase 
only 
Liberase + 
Dnase I 
Ease of dissociation ++++ ++ ++++ +++ +++ 
Clumpiness - ++ +++ ++ - 
Digestion ++++ ++ +++ +++ ++++ 
Survival (%)* 17 ± 1.7 39.5 ± 2.2 55.9 ± 1.4 46.6 ± 2.6 67.8 ± 0.7 
Median Fluoresence 
Intensity (MFI, PECAM1) 464 308 94 421 not assessed 
* proportion of live FACS events as a proportion of total sorted events 
  
  
 
 
 
 
 
Table S2 
Related to Figures 1 to 5 
List of antibodies used and their specificity. Antibodies shown in red were found to be specific and 
used in this study. Concentrations provided are for use in immunofluorescence. For Western Blot 
analysis, antibodies were used at 1:1000. For FACS, the secondary Alexa488-conjugated anti-goat 
IgG (A11055 ThermoFisher, 1:400) was used to detect the primary PDGFRβ (R+D systems) antibody. 
 
Antibody Code and Provider Concentration Specific? 
APOE Polyclonal 178479 Merck 1:250 Yes 
β-III tubulin clone 5G8 Promega 1:1000 Yes 
CD11b clone M1/70 BD 1:300 Yes 
CD13 clone EM15 eBioscience 1:100 Yes, but low signal 
CD41 clone MWReg30 BD 1:200 Yes 
CD45 clone 30-F11 BD 1:300 Yes 
IBA1 EPR16588 (ab178846) Abcam 1:1000 Yes 
ICAM2 (CD102) clone 3C4(mIC2/4) BD 1:250 Yes 
KDR (FLK1, VEGFR2) clone D-8 (sc-393163) Santa Cruz 1:200 Yes 
ITGB1 Polyclonal sc-8978 Santa Cruz 1:200 Yes 
LAMA4 CL3183 (ab242198) Abcam 1:200 Yes 
LDLR EPY1553Y (ab52818) Abcam 1:250 Yes 
LRP1 EPR3724 (ab92544) Abcam 1:250 Yes 
NG2 (CSPG4) clone 9.2.27 BD 1:100 No 
NG2 (CSPG4) Polyclonal AB5320 Millipore 1:100 No 
PDGFRβ (CD140b) clone 28D4 BD 1:200 No 
PDGFRβ (CD140b) Polyclonal AF1042 R+D systems 1:200 Yes 
PECAM1 (CD31) clone 390 eBioscience 1:250 Yes 
PECAM1 (CD31) Polyclonal ab28364 Abcam 1:100 Yes 
VTN EP873Y (ab45139) Abcam 1:200 Yes 
 
  
 Table S3 
Related to Figure 2 
List of genes most strongly enriched in neural clusters of the scRNA-seq dataset. 
Gene baseMean 
Base 
MeanA 
Base 
MeanB 
fold-
enrichment 
log2 
[enrichment] p value FDR 
Dpysl3 1.19 0.13 2.24 17.68 4.14 6.70E-130 1.90E-126 
Rtn1 1.06 0.13 2.00 15.64 3.97 6.18E-112 1.50E-108 
Tubb3 0.91 0.11 1.71 15.46 3.95 4.31E-95 8.63E-92 
Sox11 4.10 0.54 7.65 14.16 3.82 0.00E+00 0.00E+00 
Elavl3 0.78 0.11 1.45 12.94 3.69 7.76E-76 1.15E-72 
Stmn2 0.83 0.12 1.54 12.83 3.68 9.97E-80 1.79E-76 
Dcx 0.67 0.10 1.23 11.68 3.55 6.39E-62 7.76E-59 
Cd24a 1.00 0.16 1.83 11.25 3.49 1.52E-90 2.88E-87 
Nsg2 0.64 0.11 1.17 10.86 3.44 2.16E-57 2.37E-54 
Bcl11b 0.59 0.11 1.07 9.55 3.26 2.85E-49 2.55E-46 
Nnat 3.53 0.68 6.38 9.38 3.23 0.00E+00 0.00E+00 
Foxg1 0.55 0.11 0.99 9.27 3.21 1.66E-45 1.31E-42 
Elavl4 0.58 0.12 1.05 9.14 3.19 9.49E-48 7.69E-45 
Mapt 0.60 0.12 1.09 9.05 3.18 9.61E-49 8.39E-46 
Map1b 2.02 0.41 3.62 8.86 3.15 5.05E-154 2.46E-150 
Gpm6a 0.54 0.12 0.97 8.39 3.07 8.14E-43 5.90E-40 
Map2 0.61 0.13 1.10 8.37 3.07 7.11E-48 5.90E-45 
Gap43 0.50 0.11 0.90 8.29 3.05 4.32E-39 2.59E-36 
Sbk1 0.51 0.11 0.90 8.22 3.04 1.25E-39 7.86E-37 
Neurod6 0.48 0.11 0.85 7.95 2.99 1.03E-35 5.33E-33 
Igfbpl1 0.46 0.10 0.81 7.85 2.97 7.63E-35 3.71E-32 
Lhx2 0.47 0.11 0.83 7.67 2.94 3.51E-35 1.79E-32 
Meis2 0.46 0.11 0.81 7.46 2.90 1.01E-32 4.28E-30 
Pou3f3 0.46 0.11 0.80 7.45 2.90 1.01E-32 4.28E-30 
Sox2 0.49 0.12 0.86 7.38 2.88 5.39E-35 2.66E-32 
Kif5c 0.44 0.11 0.78 7.30 2.87 1.67E-31 6.67E-29 
Ina 0.45 0.11 0.79 7.23 2.85 1.01E-32 4.28E-30 
Nfib 1.75 0.43 3.06 7.05 2.82 6.69E-117 1.75E-113 
Elavl2 0.43 0.11 0.76 6.90 2.79 3.89E-30 1.52E-27 
Miat 0.42 0.11 0.74 6.87 2.78 1.93E-29 7.11E-27 
Dclk1 0.42 0.11 0.73 6.85 2.78 2.03E-28 7.26E-26 
Trim2 0.43 0.11 0.76 6.84 2.77 8.27E-30 3.09E-27 
Tubb2a|Tubb2b 2.52 0.65 4.38 6.73 2.75 3.10E-147 1.32E-143 
37865 0.40 0.10 0.70 6.73 2.75 3.22E-27 1.10E-24 
Pak3 0.43 0.11 0.74 6.52 2.70 3.66E-28 1.30E-25 
Bcl11a 0.54 0.14 0.93 6.46 2.69 1.63E-34 7.81E-32 
Runx1t1 0.42 0.11 0.73 6.34 2.67 3.64E-27 1.22E-24 
Neurod2 0.38 0.10 0.65 6.29 2.65 5.11E-25 1.58E-22 
Celf2 1.19 0.33 2.05 6.22 2.64 4.27E-73 6.05E-70 
Celf4 0.39 0.11 0.68 6.21 2.64 4.23E-25 1.32E-22 
Ank3 0.41 0.11 0.70 6.19 2.63 5.56E-26 1.77E-23 
Nfix 0.48 0.13 0.82 6.12 2.61 4.36E-30 1.67E-27 
Nsg1 0.42 0.12 0.72 6.08 2.60 4.48E-26 1.44E-23 
Gria2 0.37 0.10 0.63 6.00 2.59 9.53E-23 2.64E-20 
Cntn2 0.40 0.12 0.69 5.89 2.56 6.65E-25 2.04E-22 
Cdk5r1 0.53 0.15 0.91 5.89 2.56 4.79E-32 1.94E-29 
Dlx1 0.36 0.11 0.61 5.81 2.54 8.88E-22 2.34E-19 
Pbx1 0.88 0.26 1.49 5.74 2.52 1.06E-50 1.06E-47 
Crmp1 0.57 0.17 0.97 5.67 2.50 7.08E-33 3.13E-30 
Stmn1 2.63 0.80 4.47 5.61 2.49 4.57E-130 1.41E-126 
Basp1 2.11 0.64 3.58 5.58 2.48 1.24E-111 2.81E-108 
Tagln3 0.47 0.15 0.79 5.38 2.43 3.24E-26 1.05E-23 
Soga3 0.37 0.12 0.63 5.32 2.41 7.89E-21 1.99E-18 
Kif21a 0.37 0.12 0.62 5.23 2.39 2.29E-20 5.49E-18 
Fez1 0.34 0.11 0.57 5.21 2.38 4.40E-19 9.72E-17 
St8sia2 0.35 0.11 0.59 5.20 2.38 2.74E-19 6.22E-17 
Epha4 0.39 0.13 0.65 4.92 2.30 1.09E-20 2.68E-18 
6330403K07Rik 0.35 0.12 0.58 4.89 2.29 4.30E-18 9.04E-16 
Insm1 0.30 0.10 0.50 4.88 2.29 5.62E-16 9.75E-14 
Zfp462 0.46 0.16 0.76 4.87 2.28 7.83E-24 2.28E-21 
Pfn2 0.44 0.15 0.74 4.82 2.27 1.60E-22 4.33E-20 
Rnd2 0.32 0.11 0.53 4.82 2.27 4.73E-17 8.99E-15 
Mllt11 0.38 0.13 0.62 4.77 2.25 6.73E-19 1.47E-16 
Neurog2 0.30 0.10 0.50 4.74 2.24 2.70E-15 4.38E-13 
Kif1a 0.30 0.11 0.49 4.59 2.20 1.25E-14 1.88E-12 
Gng3 0.31 0.11 0.51 4.59 2.20 4.76E-15 7.43E-13 
Mpped2 0.35 0.13 0.57 4.57 2.19 2.17E-17 4.22E-15 
Pantr1 0.31 0.11 0.51 4.55 2.19 1.74E-15 2.88E-13 
Gm3764 0.30 0.11 0.49 4.55 2.19 1.25E-14 1.88E-12 
Tmeff1 0.32 0.12 0.52 4.54 2.18 6.64E-16 1.14E-13 
Dpysl5 0.29 0.11 0.47 4.49 2.17 2.03E-14 2.98E-12 
Tbr1 0.28 0.10 0.46 4.48 2.16 8.96E-14 1.24E-11 
Ppp2r2b 0.28 0.10 0.46 4.45 2.15 8.96E-14 1.24E-11 
Neurod1 0.27 0.10 0.45 4.38 2.13 1.46E-13 1.97E-11 
 Plxna2 0.37 0.14 0.60 4.34 2.12 1.47E-17 2.92E-15 
Cnih2 0.30 0.11 0.49 4.32 2.11 3.49E-14 4.99E-12 
Bex2 0.28 0.11 0.45 4.31 2.11 1.48E-13 2.00E-11 
Pou3f2 0.30 0.11 0.48 4.31 2.11 3.46E-14 4.97E-12 
Zbtb18 0.43 0.17 0.70 4.22 2.08 3.14E-19 7.03E-17 
Myt1l 0.26 0.10 0.42 4.22 2.08 2.77E-12 3.42E-10 
Mir124-2hg 0.27 0.10 0.43 4.20 2.07 1.70E-12 2.14E-10 
Camta1 0.31 0.12 0.50 4.20 2.07 1.32E-14 1.97E-12 
Sox5 0.32 0.12 0.51 4.14 2.05 3.46E-14 4.97E-12 
Mex3a 0.58 0.23 0.93 4.04 2.02 1.15E-23 3.31E-21 
Ndn 0.50 0.20 0.80 4.04 2.01 9.95E-21 2.47E-18 
Setbp1 0.38 0.15 0.61 4.02 2.01 2.63E-16 4.66E-14 
Ttc3 1.47 0.59 2.36 4.02 2.01 4.41E-58 5.01E-55 
Stmn3 0.27 0.11 0.43 4.02 2.01 4.37E-12 5.29E-10 
Ptprz1 0.29 0.12 0.46 4.00 2.00 2.52E-12 3.14E-10 
Srgap3 0.27 0.11 0.43 3.99 2.00 1.76E-11 2.06E-09 
Sox4 1.52 0.61 2.43 3.98 1.99 3.68E-59 4.32E-56 
Cxadr 0.25 0.10 0.41 3.96 1.99 7.55E-11 8.10E-09 
Hdgfrp3 0.33 0.13 0.52 3.92 1.97 1.33E-13 1.80E-11 
Stmn4 0.26 0.10 0.41 3.91 1.97 4.64E-11 5.13E-09 
Fezf2 0.26 0.11 0.42 3.91 1.97 2.86E-11 3.25E-09 
Rufy3 0.37 0.15 0.58 3.90 1.96 4.33E-15 6.86E-13 
Ptbp2 0.37 0.15 0.59 3.89 1.96 1.71E-15 2.85E-13 
Epha5 0.34 0.14 0.55 3.88 1.95 1.92E-14 2.83E-12 
2610203C20Rik 0.26 0.11 0.41 3.85 1.94 7.20E-11 7.80E-09 
Gnao1 0.32 0.13 0.51 3.83 1.94 3.34E-13 4.41E-11 
 
  
 Table S4 
Related to Figure 2 
List of genes most strongly enriched in mural cell clusters of the scRNA-seq dataset. 
Gene Base Mean 
Base 
MeanA 
Base 
MeanB 
fold-
enrichment 
log2 
[enrichment] p value FDR 
Rgs5 7.38 0.28 14.49 52.50 5.71 0.00E+00 0.00E+00 
Mmp9 2.34 0.14 4.54 33.12 5.05 0.00E+00 0.00E+00 
Vtn 2.02 0.15 3.90 26.66 4.74 0.00E+00 0.00E+00 
Igf2 7.50 0.65 14.34 21.97 4.46 0.00E+00 0.00E+00 
Atp1a2 1.61 0.15 3.07 20.34 4.35 2.63E-222 1.49E-218 
Abcc9 1.54 0.15 2.93 19.04 4.25 1.27E-207 6.16E-204 
Cd248 0.85 0.11 1.58 13.84 3.79 2.42E-103 6.35E-100 
Cald1 2.30 0.32 4.28 13.38 3.74 6.53E-255 4.45E-251 
Kcnj8 0.77 0.11 1.43 12.87 3.69 1.50E-91 2.83E-88 
Pcdh18 1.06 0.15 1.97 12.86 3.69 1.26E-125 4.28E-122 
Myl9 0.88 0.13 1.64 12.33 3.62 7.53E-103 1.83E-99 
Cspg4 0.75 0.11 1.38 12.29 3.62 1.74E-86 2.58E-83 
Pdgfrb 0.68 0.11 1.25 11.75 3.55 1.89E-77 2.39E-74 
Mylk 0.82 0.14 1.49 10.29 3.36 5.20E-87 8.05E-84 
Heyl 0.58 0.11 1.05 9.67 3.27 4.27E-60 3.54E-57 
Gjc1 0.96 0.19 1.74 9.29 3.22 4.00E-97 8.01E-94 
Ednra 0.56 0.11 1.01 9.05 3.18 1.31E-56 9.90E-54 
Dlk1 0.74 0.15 1.32 9.04 3.18 6.24E-74 6.85E-71 
Col3a1 0.56 0.11 1.00 8.86 3.15 3.04E-55 2.25E-52 
Rgs4 0.65 0.13 1.17 8.79 3.14 3.81E-64 3.51E-61 
Ndufa4l2 0.49 0.11 0.86 7.97 2.99 3.31E-45 1.94E-42 
Notch3 0.54 0.12 0.97 7.90 2.98 9.65E-51 6.57E-48 
F2r 0.87 0.21 1.53 7.32 2.87 2.35E-75 2.76E-72 
Fstl1 1.46 0.35 2.57 7.29 2.87 3.29E-125 1.02E-121 
Col1a2 0.43 0.11 0.76 7.08 2.82 4.32E-38 2.02E-35 
Gucy1b3 0.45 0.11 0.79 7.05 2.82 1.54E-39 7.59E-37 
Gucy1a3 0.45 0.11 0.79 6.95 2.80 1.08E-38 5.11E-36 
Atp1b2 0.51 0.14 0.89 6.54 2.71 4.68E-42 2.53E-39 
40787 1.33 0.36 2.30 6.46 2.69 1.11E-105 3.16E-102 
Ngfr 0.43 0.12 0.73 6.25 2.64 5.67E-34 2.33E-31 
S1pr3 0.38 0.10 0.65 6.22 2.64 5.22E-30 1.76E-27 
Zic1 0.91 0.26 1.57 6.12 2.61 4.22E-70 4.11E-67 
Meg3 1.97 0.57 3.37 5.95 2.57 1.55E-141 5.86E-138 
Sdc2 0.38 0.11 0.65 5.77 2.53 2.08E-28 6.80E-26 
Mfge8 0.66 0.20 1.12 5.63 2.49 1.32E-47 8.50E-45 
Farp1 0.45 0.14 0.76 5.54 2.47 1.38E-32 5.15E-30 
Axl 0.48 0.15 0.81 5.36 2.42 1.52E-33 6.10E-31 
Gm13889 0.46 0.15 0.78 5.32 2.41 3.73E-32 1.35E-29 
Gper1 0.33 0.11 0.54 4.98 2.31 6.98E-22 1.77E-19 
Uaca 0.51 0.17 0.84 4.93 2.30 5.82E-33 2.20E-30 
S100a11 0.57 0.19 0.95 4.92 2.30 4.23E-37 1.89E-34 
Tbxa2r 0.35 0.12 0.57 4.87 2.28 1.75E-22 4.59E-20 
Mmp11 0.30 0.10 0.50 4.85 2.28 3.91E-20 9.30E-18 
Pde8b 0.32 0.11 0.54 4.84 2.27 5.11E-21 1.27E-18 
Lhfp 0.36 0.12 0.59 4.81 2.27 6.04E-23 1.60E-20 
Foxd1 0.30 0.10 0.49 4.72 2.24 2.82E-19 6.27E-17 
38231 0.45 0.16 0.73 4.67 2.22 1.11E-27 3.48E-25 
Pde5a 0.37 0.13 0.60 4.54 2.18 1.18E-22 3.12E-20 
Tppp3 0.36 0.13 0.58 4.48 2.16 5.71E-22 1.46E-19 
Hspa1a|Hspa1b 0.89 0.33 1.45 4.42 2.14 1.01E-50 6.73E-48 
Bgn 1.44 0.54 2.35 4.32 2.11 3.44E-79 4.51E-76 
39326 1.39 0.52 2.26 4.31 2.11 6.70E-76 8.15E-73 
Akap12 0.61 0.23 1.00 4.31 2.11 2.67E-34 1.11E-31 
Rian 0.50 0.19 0.81 4.25 2.09 7.17E-28 2.30E-25 
Trpc3 0.28 0.11 0.46 4.24 2.08 1.95E-16 3.71E-14 
Plce1 0.29 0.11 0.47 4.22 2.08 4.05E-17 8.01E-15 
Mcam 0.82 0.31 1.32 4.22 2.08 1.35E-44 7.64E-42 
Gnas 0.85 0.33 1.38 4.20 2.07 1.40E-45 8.34E-43 
Phlda1 0.75 0.29 1.20 4.18 2.06 5.02E-40 2.59E-37 
Gadd45b 0.43 0.17 0.69 4.11 2.04 5.73E-23 1.54E-20 
Tbx2 0.29 0.11 0.46 4.10 2.04 3.97E-16 7.30E-14 
Lamb1 0.90 0.36 1.44 4.06 2.02 1.83E-46 1.16E-43 
Fos 1.75 0.69 2.81 4.06 2.02 1.83E-88 2.96E-85 
Arhgap42 0.31 0.13 0.50 3.99 2.00 3.38E-17 6.73E-15 
Arhgef17 0.30 0.12 0.47 3.96 1.99 1.33E-15 2.40E-13 
Gprc5c 0.25 0.10 0.40 3.96 1.98 1.10E-13 1.75E-11 
Nid1 1.74 0.71 2.76 3.92 1.97 6.49E-84 9.21E-81 
Ifitm3 0.35 0.14 0.56 3.87 1.95 3.05E-18 6.41E-16 
Ptn 0.64 0.26 1.02 3.87 1.95 1.22E-31 4.32E-29 
Higd1b 0.25 0.10 0.40 3.85 1.95 3.14E-13 4.82E-11 
Eva1b 0.51 0.21 0.81 3.82 1.93 6.24E-25 1.82E-22 
Tns1 0.42 0.17 0.66 3.80 1.93 1.89E-20 4.55E-18 
Epb41l1 0.31 0.13 0.49 3.77 1.92 4.84E-16 8.87E-14 
Lgals1 0.35 0.15 0.55 3.76 1.91 1.37E-17 2.82E-15 
 Cdh11 0.39 0.17 0.62 3.73 1.90 7.87E-19 1.70E-16 
Tnfrsf21 0.48 0.20 0.76 3.72 1.90 2.12E-23 5.87E-21 
Igf2r 0.51 0.22 0.80 3.66 1.87 5.83E-24 1.65E-21 
Ebf1 0.79 0.34 1.24 3.65 1.87 3.94E-36 1.72E-33 
Gstk1 0.25 0.11 0.40 3.63 1.86 6.71E-13 1.01E-10 
Afap1l2 0.25 0.11 0.40 3.63 1.86 2.12E-12 3.03E-10 
Atp7a 0.45 0.20 0.71 3.58 1.84 7.43E-21 1.83E-18 
Pdlim2 0.26 0.11 0.40 3.58 1.84 4.38E-12 6.18E-10 
Spry4 0.26 0.11 0.40 3.55 1.83 2.30E-12 3.27E-10 
Adap2 0.33 0.15 0.52 3.53 1.82 2.38E-15 4.22E-13 
Sema6d 1.00 0.44 1.56 3.53 1.82 2.05E-43 1.14E-40 
Dmd 0.26 0.11 0.41 3.53 1.82 1.92E-12 2.77E-10 
Col5a1 0.25 0.11 0.39 3.51 1.81 1.00E-11 1.36E-09 
Oaz2 0.71 0.31 1.10 3.51 1.81 8.33E-31 2.92E-28 
Timp3 0.45 0.20 0.70 3.49 1.80 1.63E-20 3.99E-18 
Sfrp2 0.25 0.11 0.38 3.46 1.79 1.00E-11 1.36E-09 
Zfp703 0.44 0.20 0.68 3.46 1.79 1.57E-19 3.56E-17 
Pid1 0.35 0.16 0.54 3.45 1.79 2.50E-15 4.40E-13 
Hic1 0.29 0.13 0.44 3.45 1.79 6.07E-13 9.22E-11 
Tlr12 0.27 0.12 0.42 3.45 1.79 1.43E-12 2.09E-10 
Tbx18 0.23 0.10 0.35 3.41 1.77 2.24E-10 2.66E-08 
Car4 0.23 0.10 0.36 3.41 1.77 6.54E-11 8.15E-09 
Rasl12 0.23 0.11 0.36 3.41 1.77 9.84E-11 1.19E-08 
Lamc3 0.23 0.11 0.36 3.39 1.76 9.84E-11 1.19E-08 
Slc19a1 0.24 0.11 0.37 3.34 1.74 7.09E-11 8.81E-09 
Myh9 0.76 0.35 1.16 3.31 1.73 1.87E-30 6.48E-28 
 
  
 Table S5 
Related to Figure 2 
List of genes most strongly enriched in endothelial clusters of the scRNA-seq dataset. 
Gene Base Mean 
Base 
MeanA 
Base 
MeanB 
fold-
enrichment 
log2 
[enrichment] p value FDR 
Cldn5 1.73 0.12 3.35 28.42 4.83 5.81E-260 9.88E-256 
Kdr 1.73 0.13 3.32 25.30 4.66 6.89E-252 7.81E-248 
Cd93 1.62 0.13 3.11 24.54 4.62 1.48E-234 1.26E-230 
Spock2 1.45 0.16 2.74 17.58 4.14 1.13E-189 5.50E-186 
Flt1 1.50 0.16 2.83 17.28 4.11 1.28E-196 7.26E-193 
Slc2a1 1.52 0.19 2.84 15.07 3.91 2.55E-189 1.08E-185 
Vwa1 0.84 0.12 1.57 12.92 3.69 3.23E-99 7.33E-96 
Slc7a5 1.38 0.21 2.55 11.86 3.57 9.76E-157 3.32E-153 
Slc38a5 0.67 0.11 1.24 11.15 3.48 5.20E-75 7.08E-72 
Ptprb 0.71 0.12 1.29 10.78 3.43 5.98E-77 8.85E-74 
Egfl7 0.76 0.13 1.38 10.76 3.43 2.26E-82 4.05E-79 
Slc7a1 1.87 0.32 3.42 10.63 3.41 2.80E-199 1.91E-195 
Tie1 0.71 0.13 1.29 9.80 3.29 1.78E-74 2.25E-71 
Pecam1 0.63 0.12 1.15 9.76 3.29 6.48E-66 7.12E-63 
Mfsd2a 0.54 0.11 0.96 8.68 3.12 8.71E-53 6.89E-50 
Mmrn2 0.55 0.12 0.98 8.49 3.09 5.38E-53 4.36E-50 
Slc38a3 0.51 0.11 0.90 8.34 3.06 2.50E-48 1.70E-45 
Htra3 0.51 0.11 0.91 7.95 2.99 1.18E-47 7.90E-45 
Cd34 0.61 0.14 1.09 7.95 2.99 1.32E-56 1.25E-53 
Cdh5 0.44 0.11 0.78 7.26 2.86 1.83E-39 1.01E-36 
Nos3 0.41 0.10 0.72 6.84 2.77 1.04E-34 4.65E-32 
Adgrl4 0.43 0.11 0.74 6.77 2.76 8.60E-36 4.01E-33 
Col18a1 0.44 0.12 0.77 6.64 2.73 1.92E-36 9.61E-34 
AU021092 0.39 0.10 0.67 6.55 2.71 1.87E-32 7.65E-30 
Slco1c1 0.40 0.11 0.70 6.49 2.70 4.12E-33 1.73E-30 
Itm2a 0.99 0.27 1.72 6.30 2.65 9.91E-77 1.41E-73 
Slc1a4 0.59 0.16 1.01 6.17 2.62 9.36E-46 6.01E-43 
Zic3 0.52 0.15 0.89 6.15 2.62 1.19E-40 6.66E-38 
Tspan18 0.50 0.14 0.85 5.85 2.55 3.01E-37 1.55E-34 
Lmo2 0.60 0.18 1.02 5.79 2.53 4.09E-44 2.44E-41 
Tfrc 0.67 0.20 1.15 5.77 2.53 1.45E-49 1.05E-46 
Ramp2 0.68 0.20 1.17 5.74 2.52 2.80E-50 2.07E-47 
Rasip1 0.41 0.12 0.70 5.72 2.52 2.68E-30 9.69E-28 
Lsr 0.38 0.11 0.64 5.69 2.51 9.28E-28 3.07E-25 
Slc40a1 0.50 0.15 0.85 5.59 2.48 6.17E-36 2.96E-33 
Myo10 0.69 0.21 1.18 5.56 2.48 1.92E-49 1.36E-46 
Eogt 0.40 0.12 0.67 5.54 2.47 1.11E-28 3.86E-26 
Limch1 0.45 0.14 0.76 5.49 2.46 1.07E-31 4.08E-29 
Sox18 0.33 0.10 0.56 5.48 2.45 6.61E-24 1.89E-21 
Plxnd1 0.43 0.14 0.73 5.36 2.42 1.31E-30 4.84E-28 
Mpzl1 0.55 0.17 0.93 5.33 2.41 9.54E-38 5.07E-35 
Slc39a8 0.40 0.13 0.67 5.26 2.40 9.99E-28 3.27E-25 
Adgrf5 0.50 0.16 0.83 5.26 2.40 8.70E-34 3.80E-31 
Aplnr 0.32 0.10 0.54 5.23 2.39 2.82E-22 7.26E-20 
Slc6a6 1.05 0.35 1.76 5.08 2.34 7.13E-68 8.37E-65 
Slc38a2 2.31 0.77 3.86 5.03 2.33 1.32E-134 4.07E-131 
Abcb1a 0.31 0.10 0.51 4.92 2.30 4.16E-20 9.83E-18 
Prnp 0.49 0.17 0.81 4.92 2.30 2.15E-31 8.06E-29 
Tsc22d1 2.10 0.71 3.48 4.87 2.29 6.04E-123 1.58E-119 
Slc39a10 0.61 0.21 1.01 4.72 2.24 6.00E-38 3.24E-35 
Apod 0.90 0.32 1.49 4.68 2.23 2.84E-54 2.42E-51 
Lrp8 0.38 0.14 0.62 4.55 2.18 8.99E-23 2.39E-20 
Thsd1 0.30 0.11 0.49 4.54 2.18 4.32E-18 9.20E-16 
Robo4 0.28 0.10 0.46 4.53 2.18 1.35E-17 2.72E-15 
Ccnjl 0.38 0.14 0.63 4.51 2.17 3.75E-23 1.03E-20 
Enpp2 0.29 0.10 0.47 4.50 2.17 2.17E-17 4.30E-15 
Apln 0.29 0.10 0.47 4.48 2.16 2.17E-17 4.30E-15 
Plvap 0.30 0.11 0.50 4.47 2.16 8.61E-19 1.91E-16 
Bsg 0.97 0.36 1.58 4.43 2.15 1.36E-54 1.18E-51 
Sox17 0.28 0.10 0.45 4.42 2.14 5.71E-17 1.09E-14 
Nampt 0.49 0.18 0.81 4.40 2.14 1.89E-28 6.49E-26 
Palmd 0.31 0.11 0.50 4.39 2.13 2.57E-18 5.56E-16 
Eng 0.49 0.18 0.80 4.37 2.13 3.94E-28 1.31E-25 
Kank3 0.30 0.11 0.49 4.36 2.12 4.87E-18 1.03E-15 
Tek 0.40 0.15 0.65 4.34 2.12 1.16E-22 3.05E-20 
Pde8a 0.33 0.12 0.53 4.33 2.12 8.93E-19 1.97E-16 
Ctla2a 0.30 0.11 0.48 4.32 2.11 3.97E-17 7.59E-15 
Mllt4 0.57 0.22 0.93 4.27 2.10 1.39E-31 5.24E-29 
Podxl 0.31 0.12 0.50 4.27 2.10 7.15E-18 1.48E-15 
Dock9 0.31 0.12 0.50 4.26 2.09 7.15E-18 1.48E-15 
Ablim1 0.58 0.22 0.94 4.24 2.08 2.88E-32 1.17E-29 
Gja1 0.28 0.11 0.45 4.19 2.07 4.57E-16 8.14E-14 
Ece1 0.31 0.12 0.49 4.13 2.05 7.03E-17 1.32E-14 
 Myh10 0.85 0.33 1.37 4.12 2.04 1.04E-44 6.43E-42 
Erg 0.26 0.10 0.41 4.10 2.03 2.53E-14 4.01E-12 
Esam 0.69 0.27 1.11 4.06 2.02 5.78E-36 2.81E-33 
Gm28045|Prnd 0.25 0.10 0.40 4.02 2.01 1.47E-13 2.18E-11 
Mecom 0.27 0.11 0.43 4.01 2.00 1.35E-14 2.19E-12 
Cyyr1 0.27 0.11 0.43 4.00 2.00 2.07E-14 3.32E-12 
Sh3bp5 0.42 0.17 0.68 4.00 2.00 6.14E-22 1.57E-19 
Adm 0.31 0.12 0.49 3.99 2.00 2.09E-16 3.83E-14 
Kcp 0.34 0.14 0.54 3.98 1.99 3.82E-18 8.23E-16 
Cdc42ep3 0.31 0.13 0.49 3.94 1.98 4.64E-16 8.22E-14 
Sema6a 0.65 0.26 1.04 3.93 1.98 2.95E-32 1.18E-29 
Fli1 0.40 0.16 0.64 3.89 1.96 1.58E-20 3.81E-18 
Ccdc141 0.39 0.16 0.62 3.87 1.95 7.16E-20 1.67E-17 
Ptprg 0.48 0.20 0.77 3.87 1.95 2.69E-24 7.91E-22 
Plk2 0.34 0.14 0.54 3.82 1.93 2.88E-17 5.57E-15 
Ecscr 0.38 0.16 0.60 3.82 1.93 2.14E-19 4.93E-17 
Dok4 0.27 0.11 0.43 3.80 1.93 4.26E-14 6.65E-12 
Csrp2 0.47 0.20 0.74 3.76 1.91 1.11E-22 2.92E-20 
Lef1 0.29 0.12 0.46 3.76 1.91 1.61E-14 2.58E-12 
Fn1 1.23 0.52 1.95 3.75 1.91 4.92E-57 4.78E-54 
Efna1 0.25 0.11 0.40 3.72 1.90 1.61E-12 2.19E-10 
Slc3a2 1.80 0.77 2.83 3.69 1.88 1.96E-80 3.18E-77 
Sox7 0.24 0.10 0.38 3.68 1.88 8.83E-12 1.15E-09 
Adamtsl2 0.23 0.10 0.37 3.67 1.88 1.12E-11 1.43E-09 
Abca1 0.93 0.40 1.46 3.67 1.88 3.11E-42 1.76E-39 
Tdrp 0.24 0.10 0.37 3.62 1.86 6.17E-12 8.11E-10 
Apcdd1 0.28 0.12 0.44 3.60 1.85 1.87E-13 2.67E-11 
 
  
 Table S6 
Related to Figure 2 
List of genes most strongly enriched in the microglia cluster of the scRNA-seq dataset. 
Gene Base Mean 
Base 
MeanA 
Base 
MeanB 
fold-
enrichment 
log2 
[enrichment] p value FDR 
C1qb 3.56 0.20 6.93 34.99 5.13 0.00E+00 0.00E+00 
Ctss 2.87 0.17 5.57 33.32 5.06 0.00E+00 0.00E+00 
C1qc 2.13 0.14 4.13 29.80 4.90 0.00E+00 0.00E+00 
Csf1r 2.28 0.15 4.40 28.70 4.84 0.00E+00 0.00E+00 
Ly86 1.76 0.12 3.39 27.79 4.80 7.45E-222 2.54E-218 
Hexb 2.26 0.18 4.34 24.59 4.62 0.00E+00 0.00E+00 
Ccl4 1.33 0.12 2.53 21.13 4.40 1.72E-155 3.08E-152 
Cx3cr1 1.38 0.12 2.64 21.12 4.40 4.75E-161 1.01E-157 
P2ry12 1.25 0.11 2.38 20.79 4.38 8.41E-145 1.30E-141 
Fcer1g 1.38 0.13 2.62 20.05 4.33 9.43E-158 1.78E-154 
Fcrls 1.24 0.12 2.35 19.62 4.29 1.46E-141 2.16E-138 
Apoe 7.48 0.76 14.21 18.62 4.22 0.00E+00 0.00E+00 
Mpeg1 1.15 0.12 2.18 18.48 4.21 5.02E-129 6.84E-126 
C3ar1 1.18 0.12 2.24 18.02 4.17 7.47E-131 1.06E-127 
Ctsd 2.35 0.25 4.45 17.67 4.14 0.00E+00 0.00E+00 
Ctsb 4.30 0.47 8.13 17.24 4.11 0.00E+00 0.00E+00 
Lgmn 1.52 0.17 2.88 17.05 4.09 5.47E-165 1.24E-161 
C1qa 0.99 0.11 1.87 16.55 4.05 1.13E-106 1.33E-103 
Tyrobp 0.87 0.11 1.64 15.01 3.91 1.02E-90 1.06E-87 
Cd53 0.96 0.14 1.78 12.92 3.69 6.42E-94 6.83E-91 
Laptm5 1.96 0.30 3.63 11.96 3.58 3.23E-179 7.84E-176 
Kctd12 0.95 0.16 1.73 11.17 3.48 6.03E-86 5.86E-83 
Atf3 1.46 0.26 2.66 10.32 3.37 4.75E-126 6.22E-123 
Lyz1|Lyz2 0.64 0.11 1.16 10.24 3.36 3.82E-56 2.50E-53 
Fcgr3 0.62 0.11 1.13 10.07 3.33 2.52E-54 1.56E-51 
Hpgds 0.67 0.12 1.22 10.06 3.33 9.10E-58 6.20E-55 
Grn 1.92 0.35 3.48 9.99 3.32 1.08E-159 2.16E-156 
Plek 0.61 0.11 1.10 9.71 3.28 1.21E-51 7.00E-49 
Ccl3 0.71 0.14 1.29 9.40 3.23 2.24E-59 1.66E-56 
Cd83 0.66 0.13 1.20 9.37 3.23 6.01E-55 3.86E-52 
Coro1a 0.58 0.11 1.06 9.25 3.21 6.79E-48 3.67E-45 
Ctsl 1.49 0.30 2.68 8.97 3.16 3.02E-118 3.80E-115 
Aif1 0.54 0.11 0.97 8.91 3.15 1.28E-43 6.04E-41 
Siglech 0.51 0.10 0.91 8.76 3.13 5.42E-41 2.22E-38 
Cst3 2.89 0.60 5.17 8.58 3.10 7.51E-194 2.32E-190 
Ptgs1 0.53 0.11 0.95 8.49 3.09 3.89E-42 1.70E-39 
Sirpa 0.65 0.14 1.16 8.47 3.08 3.74E-51 2.12E-48 
Lpl 0.64 0.14 1.14 7.90 2.98 1.65E-47 8.77E-45 
Cd52 0.45 0.10 0.79 7.65 2.94 1.77E-33 5.90E-31 
Bin2 0.52 0.12 0.91 7.55 2.92 1.28E-37 4.85E-35 
Spp1 0.43 0.10 0.75 7.37 2.88 3.26E-31 1.00E-28 
Itgam 0.46 0.11 0.80 7.27 2.86 6.08E-33 2.01E-30 
Olfml3 0.59 0.14 1.03 7.26 2.86 6.20E-42 2.67E-39 
Trem2 0.43 0.10 0.75 7.23 2.85 7.25E-31 2.18E-28 
Ly6e 0.76 0.19 1.34 7.23 2.85 5.09E-54 3.04E-51 
Ncf1 0.43 0.11 0.76 7.02 2.81 2.29E-30 6.79E-28 
P2ry13 0.43 0.11 0.76 6.90 2.79 2.29E-30 6.79E-28 
Cfh 0.50 0.13 0.87 6.88 2.78 2.37E-34 8.16E-32 
B2m 2.47 0.63 4.31 6.82 2.77 4.58E-148 7.80E-145 
Pld4 0.41 0.11 0.72 6.77 2.76 1.78E-28 5.08E-26 
Adgre1 0.40 0.10 0.70 6.76 2.76 8.69E-28 2.37E-25 
Evi2a 0.42 0.11 0.72 6.67 2.74 7.84E-28 2.15E-25 
Unc93b1 0.49 0.13 0.85 6.64 2.73 1.09E-32 3.47E-30 
Il1a 0.40 0.11 0.70 6.56 2.71 3.81E-27 1.01E-24 
Fyb 0.40 0.11 0.70 6.55 2.71 1.21E-26 3.16E-24 
Psap 1.14 0.31 1.97 6.45 2.69 1.40E-72 1.17E-69 
Apbb1ip 0.38 0.10 0.65 6.42 2.68 4.36E-25 1.02E-22 
Cd180 0.36 0.10 0.63 6.17 2.63 1.34E-23 2.92E-21 
Cd33 0.40 0.11 0.70 6.06 2.60 1.98E-25 4.78E-23 
Il6ra 0.40 0.12 0.69 5.99 2.58 1.98E-25 4.78E-23 
Cyth4 0.39 0.11 0.67 5.99 2.58 1.47E-24 3.37E-22 
Ctsz 0.85 0.25 1.45 5.93 2.57 9.97E-51 5.48E-48 
Tgfbr1 0.73 0.21 1.25 5.88 2.56 4.12E-43 1.92E-40 
Pde3b 0.43 0.12 0.73 5.87 2.55 6.47E-26 1.61E-23 
Nckap1l 0.36 0.11 0.61 5.79 2.53 4.86E-22 9.62E-20 
Gpr34 0.35 0.10 0.60 5.78 2.53 7.63E-22 1.50E-19 
Rnase4 0.80 0.24 1.36 5.77 2.53 2.12E-46 1.08E-43 
Rac2 0.37 0.11 0.63 5.72 2.52 3.76E-22 7.49E-20 
Arhgap25 0.44 0.13 0.74 5.61 2.49 9.54E-26 2.34E-23 
Serinc3 2.18 0.67 3.69 5.51 2.46 4.48E-113 5.45E-110 
Ctsc 0.57 0.18 0.96 5.34 2.42 1.86E-31 5.75E-29 
Man2b1 0.48 0.15 0.80 5.34 2.42 1.33E-26 3.47E-24 
Pou2f2 0.46 0.15 0.78 5.33 2.41 5.32E-26 1.33E-23 
 Myo1f 0.33 0.11 0.56 5.29 2.40 9.81E-19 1.63E-16 
Tpd52 0.43 0.14 0.73 5.23 2.39 5.22E-24 1.16E-21 
Ptpn6 0.40 0.13 0.68 5.21 2.38 1.53E-22 3.18E-20 
Lpcat2 0.32 0.10 0.54 5.20 2.38 2.84E-18 4.65E-16 
Ptprc 0.34 0.11 0.57 5.19 2.38 3.87E-19 6.55E-17 
Maf 0.68 0.22 1.14 5.17 2.37 7.56E-37 2.77E-34 
Selplg 0.33 0.11 0.55 5.17 2.37 2.84E-18 4.65E-16 
Gusb 0.66 0.22 1.10 5.07 2.34 2.30E-34 7.98E-32 
Ncf2 0.38 0.13 0.64 5.02 2.33 1.65E-20 3.04E-18 
Rgs10 0.39 0.13 0.65 5.00 2.32 3.64E-21 6.85E-19 
Mt1 0.43 0.14 0.72 4.97 2.31 2.42E-22 4.87E-20 
Cd9 0.49 0.16 0.81 4.96 2.31 2.80E-25 6.63E-23 
Abhd12 0.46 0.16 0.77 4.86 2.28 9.00E-24 1.98E-21 
Lgals9 0.46 0.16 0.77 4.84 2.28 9.00E-24 1.98E-21 
Trib1 0.59 0.20 0.97 4.82 2.27 3.73E-29 1.07E-26 
Cd84 0.32 0.11 0.53 4.76 2.25 3.47E-16 5.14E-14 
Arpc1b 1.23 0.43 2.03 4.74 2.25 5.23E-59 3.71E-56 
Neat1 0.42 0.15 0.70 4.73 2.24 2.04E-21 3.87E-19 
Plin2 0.51 0.18 0.83 4.62 2.21 1.05E-24 2.42E-22 
Ifrd1 0.69 0.25 1.14 4.62 2.21 8.82E-33 2.89E-30 
Vsir 0.36 0.13 0.59 4.59 2.20 7.76E-18 1.25E-15 
Runx1 0.32 0.11 0.52 4.57 2.19 1.00E-15 1.44E-13 
Parvg 0.30 0.11 0.49 4.55 2.19 6.75E-15 9.26E-13 
Ifi30 0.36 0.13 0.59 4.55 2.18 1.31E-17 2.09E-15 
Hexa 0.46 0.17 0.75 4.52 2.18 1.57E-21 3.02E-19 
Sgpl1 0.44 0.16 0.71 4.51 2.17 1.05E-20 1.94E-18 
Arl4c 0.40 0.15 0.66 4.49 2.17 4.89E-19 8.21E-17 
 
  
 Table S7 
Related to Figure 3 
Top 50 enriched genes in the EMBRACE-isolated neural population (CD45neg, CD41neg, CD11bneg, 
PECAM1neg, CD102neg, PDGFRβneg). 
Gene baseMean log2FC p value FDR 
Gm42418 4045.63 15.89 3.35E-88 6.93E-85 
Ptprn2 294.82 11.60 6.49E-55 3.42E-52 
Slc32a1 220.18 11.50 3.14E-55 1.72E-52 
Gm8203 177.07 11.48 1.41E-49 5.10E-47 
Xkr7 169.99 11.43 2.44E-50 9.79E-48 
Ecel1 166.55 11.40 3.71E-49 1.31E-46 
Pdcd2 132.45 11.08 1.11E-46 3.44E-44 
Myo16 194.24 11.02 5.57E-53 2.63E-50 
Nalcn 119.54 10.93 1.08E-45 3.19E-43 
Shisa6 106.85 10.77 1.68E-43 4.30E-41 
Gpr26 129.34 10.74 4.48E-47 1.43E-44 
Uncx 157.31 10.69 1.16E-43 3.02E-41 
Gjd2 90.05 10.52 4.59E-41 9.78E-39 
Tmem28 106.58 10.46 7.67E-43 1.89E-40 
Fam189a1 105.19 10.45 1.83E-44 4.97E-42 
Rtn4r 85.74 10.44 6.58E-38 1.14E-35 
Reln 1791.73 10.40 6.61E-18 2.21E-16 
Grm4 79.77 10.35 1.27E-39 2.42E-37 
Islr2 4212.44 10.33 2.29E-31 2.54E-29 
Lrrn2 270.23 10.25 3.59E-65 3.32E-62 
Tmem59l 111.39 10.23 3.44E-45 9.72E-43 
Kndc1 90.12 10.23 1.93E-42 4.52E-40 
Erbb4 334.30 10.20 2.55E-63 2.21E-60 
Gm12481 69.70 10.14 3.11E-35 4.52E-33 
Miat 13098.89 10.09 2.87E-46 8.66E-44 
Gm5812 64.73 10.05 8.99E-37 1.50E-34 
Hrh3 76.46 10.00 4.83E-39 8.89E-37 
Gabra3 141.92 10.00 5.50E-47 1.74E-44 
Mmp24 430.49 9.99 1.46E-11 2.30E-10 
Galnt14 61.39 9.98 5.85E-36 9.08E-34 
Zim1 94.94 9.96 2.45E-35 3.60E-33 
Sorcs3 75.21 9.95 3.73E-36 5.96E-34 
Magel2 868.39 9.94 2.44E-27 2.01E-25 
Frmpd3 91.12 9.92 1.82E-37 3.10E-35 
Epha8 87.93 9.90 2.04E-41 4.42E-39 
Chrna3 56.23 9.84 1.61E-33 2.18E-31 
Kcnf1 66.83 9.80 1.81E-38 3.25E-36 
Disp2 604.76 9.78 9.20E-14 1.93E-12 
Thsd7b 65.77 9.76 4.70E-36 7.38E-34 
Gm996 63.80 9.74 2.76E-38 4.85E-36 
Gm27032 51.06 9.71 8.27E-34 1.13E-31 
Scg2 118.04 9.69 5.71E-18 1.92E-16 
Tunar 47.92 9.62 3.46E-32 4.22E-30 
Tenm1 73.28 9.57 1.08E-30 1.12E-28 
Zfhx2os 56.80 9.57 2.86E-36 4.63E-34 
Lgi2 46.12 9.57 3.54E-32 4.31E-30 
Rgs7 46.23 9.56 2.44E-30 2.46E-28 
Adcyap1 44.62 9.51 2.42E-31 2.68E-29 
Syde2 54.11 9.50 7.23E-36 1.12E-33 
Cnpy1 357.67 9.38 2.14E-16 6.08E-15 
 
  
 Table S8 
Related to Figure 3 
Top 50 enriched genes in the EMBRACE-isolated mural cell population (PDGFRβhigh, PECAM1neg, 
CD102neg, CD45neg, CD41neg, CD11bneg). Due to their high abundance in the list, genes with the Gm 
prefix were removed from this list.  
Gene baseMean log2FC p value FDR 
Kcne4 933.90 12.51 1.60E-38 4.74E-35 
Cpa1 309.65 11.90 9.97E-44 4.72E-40 
Ednra 5589.26 11.86 2.58E-43 1.02E-39 
Atp13a5 616.11 10.83 3.05E-18 1.90E-15 
Enpep 222.42 10.58 1.57E-47 9.30E-44 
Mmp9 11155.83 10.36 6.24E-20 5.09E-17 
Alx1 156.94 10.25 2.15E-29 3.91E-26 
Hcar1 87.23 10.23 1.15E-21 1.23E-18 
Slc6a20a 254.82 10.03 2.22E-18 1.46E-15 
4933431K23Rik 69.23 9.75 3.23E-26 4.78E-23 
Rarres2 185.96 9.74 2.22E-35 5.83E-32 
Vtn 12818.27 9.42 3.07E-15 1.17E-12 
B830012L14Rik 214.23 9.27 1.53E-59 1.81E-55 
Sod3 359.20 9.26 4.10E-31 8.82E-28 
8030451A03Rik 84.20 9.05 3.30E-16 1.62E-13 
Tbx18 406.60 8.69 2.12E-15 8.51E-13 
Akr1c12 33.37 8.68 1.15E-11 2.12E-09 
Vpreb3 30.63 8.61 4.61E-20 3.90E-17 
Cd248 1895.31 8.12 2.09E-17 1.12E-14 
Art3 1845.52 8.07 6.34E-24 7.89E-21 
Ins2 22.41 8.03 5.27E-09 4.95E-07 
Slc38a11 137.30 7.98 2.29E-19 1.75E-16 
Postn 605.46 7.86 1.90E-15 7.76E-13 
C1qtnf2 86.03 7.84 9.73E-16 4.19E-13 
Myocd 30.12 7.81 6.25E-15 2.24E-12 
1600015I10Rik 15.33 7.71 2.61E-10 3.52E-08 
4921534H16Rik 16.11 7.61 2.30E-08 1.84E-06 
Mylk4 86.57 7.57 2.05E-22 2.31E-19 
Vstm4 663.01 7.55 4.08E-07 2.27E-05 
Ndufa4l2 6822.54 7.55 2.89E-10 3.83E-08 
Cspg4 2288.33 7.50 5.72E-12 1.14E-09 
Krtdap 16.93 7.44 1.73E-06 7.67E-05 
Kcnmb1 228.04 7.43 2.18E-08 1.75E-06 
Myl9 8993.35 7.31 2.34E-24 3.08E-21 
S1pr3 3632.06 7.28 5.15E-06 1.91E-04 
S1pr3 3632.06 7.28 5.15E-06 0.000191 
Npn2 12.38 7.25 1.29E-07 8.36E-06 
2010003K11Rik 14.42 7.25 0.000873 0.010468 
Col6a3 192.08 7.23 4.75E-07 2.56E-05 
Rgs4 13901.09 7.21 9.88E-09 8.63E-07 
Prss45 11.53 7.20 6.59E-08 4.64E-06 
Bmp5 317.08 7.20 5.23E-07 2.78E-05 
Lamc3 717.82 7.15 1.01E-07 6.79E-06 
C1qtnf7 13.84 7.14 5.78E-09 5.34E-07 
Gpr20 56.94 7.14 2.08E-08 1.69E-06 
Tmc5 112.89 7.14 2.50E-07 1.50E-05 
Des 125.96 7.12 2.75E-08 2.16E-06 
Tnxb 106.90 7.11 6.84E-08 4.79E-06 
Crygc 10.94 7.06 4.19E-07 2.32E-05 
Higd1b 2370.20 7.00 8.42E-04 1.02E-02 
 
  
 Table S9 
Related to Figure 3 
Top 50 enriched genes in the EMBRACE-isolated endothelial cell population (PECAM1pos, CD102pos, 
CD45neg, CD41neg, CD11bneg, PDGFRβneg). 
Gene baseMean log2FC p value FDR 
Myct1 675.89 12.81 1.24E-57 1.43E-53 
Mogat2 510.34 12.66 4.39E-44 2.53E-40 
Gimap4 332.25 12.38 8.88E-31 1.86E-27 
Kcne3 362.22 12.19 3.43E-21 3.44E-18 
Tbx1 339.36 11.70 4.42E-30 8.48E-27 
Gm38197 377.99 11.45 1.09E-31 3.15E-28 
Mall 212.27 11.43 4.55E-26 6.97E-23 
Igsf5 101.69 10.67 2.16E-20 1.85E-17 
Cfi 107.66 10.44 1.54E-33 5.05E-30 
Nos3 1955.22 10.35 7.87E-34 3.02E-30 
4930578C19Rik 85.41 9.91 8.92E-11 1.35E-08 
A530016L24Rik 62.83 9.75 1.01E-12 2.38E-10 
Gm37393 60.31 9.73 3.53E-13 9.23E-11 
Gm694 47.25 9.73 7.35E-20 5.83E-17 
Cldn5 14488.32 9.54 3.02E-09 3.26E-07 
Rassf9 951.34 9.30 4.94E-13 1.23E-10 
Gm12866 37.97 9.29 8.43E-15 2.85E-12 
Rp1 108.20 9.28 1.92E-24 2.60E-21 
Foxl2 237.78 9.27 1.61E-24 2.32E-21 
Ces2b 53.19 9.22 4.80E-09 4.80E-07 
BB365896 39.02 9.12 4.63E-17 2.42E-14 
Clca2 51.76 9.02 1.13E-10 1.67E-08 
Slc38a5 6137.35 9.00 4.45E-12 9.40E-10 
Serpinb9b 78.97 8.98 2.89E-14 8.98E-12 
9930038B18Rik 30.18 8.92 9.08E-13 2.18E-10 
Mmrn1 1127.35 8.85 6.41E-15 2.23E-12 
Gm38066 35.10 8.85 1.36E-09 1.62E-07 
Psg17 39.10 8.83 1.70E-15 6.54E-13 
Aplnr 4161.45 8.75 6.14E-08 4.53E-06 
Gpihbp1 25.07 8.72 3.72E-13 9.51E-11 
Unc45b 275.01 8.69 5.60E-11 8.99E-09 
Vwa1 4369.62 8.68 3.22E-16 1.51E-13 
Adgrl4 3021.45 8.58 3.63E-12 7.80E-10 
Gpr143 32.49 8.44 8.44E-05 2.00E-03 
Rhbdl2 262.17 8.40 1.98E-09 2.22E-07 
Gm24283 36.06 8.40 1.53E-15 5.96E-13 
Hapln1 232.78 8.30 8.39E-12 1.69E-09 
Acsbg2 20.54 8.23 4.01E-09 4.18E-07 
Myzap 406.72 8.20 2.11E-11 3.73E-09 
Slco1c1 1776.55 8.20 4.04E-11 6.69E-09 
Allc 22.61 8.15 3.07E-10 4.22E-08 
Ushbp1 1659.27 8.13 9.69E-14 2.79E-11 
Ptgis 730.64 8.03 9.58E-10 1.18E-07 
Shbg 32.10 8.01 1.37E-09 1.63E-07 
T 121.42 7.97 2.40E-10 3.37E-08 
Prnd 159.22 7.92 3.75E-12 8.00E-10 
Tecrl 18.10 7.86 2.62E-04 4.75E-03 
Gm10258 22.95 7.84 8.03E-06 2.95E-04 
Nos2 173.31 7.84 3.26E-10 4.47E-08 
Foxl2os 56.12 7.84 2.04E-13 5.65E-11 
 
  
 Table S10 
Related to Figure 3 
Top 50 enriched genes in the EMBRACE-isolated microglia population (CD45medium, CD11bpos, 
PECAM1neg, PDGFRβneg). 
Gene baseMean log2FC p value FDR 
Ctss 17584.46 17.68 2.32E-101 1.34E-97 
Fcrls 15462.25 17.49 2.86E-99 1.32E-95 
C1qc 13028.88 17.28 1.30E-101 9.95E-98 
C1qb 17918.06 17.00 9.11E-130 1.05E-125 
Fcgr3 7037.22 16.41 8.74E-90 3.36E-86 
Ly86 4920.81 15.86 1.77E-77 3.72E-74 
Trem2 4014.58 15.60 3.87E-78 8.92E-75 
Adgre1 4387.59 15.24 3.40E-89 1.12E-85 
C1qa 6834.11 15.16 1.14E-65 1.46E-62 
Cd86 2583.89 15.14 1.60E-53 1.19E-50 
Rgs1 1985.73 14.89 2.03E-61 2.34E-58 
Cd84 2662.58 14.87 1.88E-55 1.61E-52 
Siglech 3729.47 14.83 7.10E-76 1.28E-72 
Tyrobp 4861.84 14.64 2.33E-41 1.12E-38 
Rac2 3191.76 14.64 1.21E-73 1.86E-70 
Spi1 3588.60 14.36 1.16E-78 2.98E-75 
Clec5a 891.88 13.80 2.07E-54 1.64E-51 
Ms4a6d 926.47 13.73 3.11E-44 1.59E-41 
Ncf4 831.95 13.69 8.01E-53 5.77E-50 
Tifab 957.65 13.57 7.27E-57 7.28E-54 
Ms4a6b 924.84 13.51 2.27E-54 1.75E-51 
Ms4a6c 760.16 13.51 2.13E-46 1.17E-43 
Cd53 3796.61 13.49 5.30E-55 4.36E-52 
Abcg3 828.87 13.35 1.77E-52 1.20E-49 
Sash3 1171.07 13.34 2.82E-59 2.95E-56 
Cd300c2 769.03 13.31 1.25E-59 1.37E-56 
Ccr1 612.11 13.06 3.84E-35 1.38E-32 
Bank1 644.68 13.05 1.27E-55 1.17E-52 
Cx3cr1 13140.39 13.04 1.92E-39 8.06E-37 
Tnfaip8l2 629.37 12.96 2.04E-49 1.24E-46 
Ccl12 527.37 12.94 1.37E-38 5.53E-36 
Clec7a 525.75 12.91 5.20E-37 2.00E-34 
Itgam 1330.38 12.88 4.69E-66 6.36E-63 
Nlrp3 826.51 12.85 1.76E-55 1.56E-52 
Cd48 466.81 12.84 7.48E-43 3.67E-40 
Casp1 706.43 12.82 1.63E-52 1.14E-49 
Dock2 2034.59 12.81 3.76E-29 9.11E-27 
Ptprc 4962.73 12.81 2.46E-37 9.62E-35 
Ly9 405.13 12.70 4.00E-46 2.10E-43 
Ccl9 656.87 12.66 6.82E-48 3.93E-45 
A130071D04Rik 596.88 12.65 8.07E-33 2.55E-30 
Il1b 396.85 12.60 1.40E-40 6.21E-38 
Gm1966 423.74 12.60 1.50E-34 5.24E-32 
Cd300lf 394.87 12.52 3.72E-35 1.36E-32 
Blnk 1015.81 12.35 1.42E-70 2.05E-67 
Nlrp1b 388.92 12.31 1.83E-46 1.03E-43 
Crybb1 2631.46 12.20 2.47E-19 2.79E-17 
Aif1 5410.21 12.20 2.00E-22 2.93E-20 
Fcgr2b 339.37 12.16 2.28E-48 1.34E-45 
Bcl2a1b 268.20 12.11 4.77E-41 2.20E-38 
 
  
 TRANSPARENT METHODS 
 
Animals 
All animal studies were performed according to the German animal care and ethics legislation and 
approved by the Committee on Research Animal Care, Regierungspräsidium Freiburg. Mice were 
maintained on a C57BL/6 background, under a 12-hour light and dark cycle and water and standard 
chow were provided ad libitum. The morning after a vaginal plug was detected was designated E0.5. 
 
Brain dissociation 
Brains from E14.5 embryos were acutely isolated and meninges were removed under a dissecting 
microscope. Four methods were trialed, with Liberase + DNase I performing the best according to cell 
survival, overall digestion as well as the retention of cell surface markers (Table S1). Each of the 
methodologies is detailed below.  
Liberase and DNase I 
E14.5 brains were transferred to 1.5 ml eppendorf tubes. To each tube, 475 µl of PBS containing 5 
mM MgCl2, 20 µl DNase I (final concentration 80 U/ml, New England Biolabs #M0303) and 5 µl 
Liberase TM (final concentration 0.13 WU/ml, Roche 05401119001) were added. Samples were 
incubated in a thermomixer (37°C, 800 rpm) for 40 minutes. Samples were gently triturated using a 
P1000 pipette at 20 minutes and again at the end of the 40 minutes. Samples were filtered through a 
100 µm sieve and cells collected by centrifugation (250 g, room temperature, 4 minutes, swing bucket 
rotor) and resuspended in FACS buffer (PBS supplemented with 2% fetal calf serum).  
The same methodology was used for the Liberase only test, with the exception that DNase I was 
excluded. 
Pancreatin trypsin 
Embryonic E14.5 brains were transferred to 500 µl dissociation solution containing 2.5% w/v 
pancreatin (Sigma P3292) and 0.5% w/v trypsin (Gibco 27250-018) in PBS. Tubes were incubated on 
ice for 30 minutes and flicked occasionally to ensure mixing. After 30 minutes, the dissociation solution 
was removed and samples incubated at 37°C for 5 minutes in a water bath. Next, 2% FCS / PBS was 
added and the brains mechanically dissociated using a P1000 pipette and passed through a 100 µm 
sieve prior to analysis.  
Collagenase and dispase 
Collagenase and Dispase were purchased from Roche (10269638001) and used according to the 
manufacturer’s recommendations at a concentration of 1 mg/ml (w/v). 
No enzyme 
E14.5 brains were placed in FACS buffer and triturated ~10 times using a P1000 pipette. Samples 
were collected by centrifugation (250 g, room temperature, 4 minutes, swing bucket rotor) and tested 
for cell viability. 
  
Flow cytometry 
Dissociated E14.5 brains were washed once in PBS supplemented with 5 mM MgCl2. Cells were 
passed through a 100 µm sieve, resuspended in 400 µl FACS buffer (PBS + 2% fetal calf serum) 
containing the PDGFRβ antibody (R+D, Table S2) and incubated on ice for 30 minutes. After two 
washes in FACS buffer at 4°C, cells were resuspended in 400 µl FACS buffer containing antibodies 
raised against CD11b, CD41, CD45, CD102 (ICAM2) and PECAM1 (CD31) as well as the Alexa488-
conjugated anti-goat IgG (ThermoFisher A11055) at the indicated concentrations (Table S2). Zombie 
dye (Biolegend 423106, 1:200) was added to the mix as a viability marker. Cells were incubated on ice 
for 45 minutes, washed three times in ice cold FACS buffer, collected by centrifugation (250 g, 4°C) in 
a swinging bucket rotor and sorted on the FACS ARIA (BD Biosciences) using a 100 µm nozzle. For 
scRNA-seq analysis, cells were sorted into 384 well plates and processed according to the mCEL-
Seq2 protocol (see below). For bulk populations, cells were collected in ice-cold FACS buffer, 
centrifuged (300 g, 4 minutes, 4°C) in a swing bucket rotor. Cell pellets were snap frozen and stored at 
-80°C. RNA from neural cells was isolated using the Qiagen mini kit (#74104), while RNA from mural 
cells, endothelial cells and microglia was extracted using the Qiagen miRNeasy Micro kit (#1071023). 
Libraries for RNA-seq of the neural population were prepared using the Illumina TruSeq library 
preparation kit. For mural cells, endothelial cells and microglia, cDNA was prepared from isolated RNA 
using the SMART-Seq v4 Ultra Low Input RNA Kit for Sequencing (Clontech 634891). Libraries were 
prepared using the Nextera XT DNA library preparation kit (Illumina FC-131-1096) and sequenced on 
the HiSeq 2500 instrument. 
 
Single cell RNA sequencing 
scRNA-seq was performed according to the mCEL-Seq2 protocol (Hashimshony et al., 2016; Herman 
et al., 2018). Single cells were index sorted into 384-well plates containing 240 nl of primer mix and 
1.2 µl of mineral oil (Sigma-Aldrich). A FACS-ID for each individual well was assigned according to the 
gating strategy. The plates were centrifuged at 2200 g for 10 minutes at 4°C, snap-frozen in liquid 
nitrogen and stored at −80°C until processing. RNA was reverse transcribed using 160 nl of reverse 
transcription reaction mix and 2.2 µl of second strand reaction mix. cDNA from 96 cells was pooled 
together before clean up and in vitro transcription, generating 4 libraries from each 384-well plate. 0.8 
µl of AMPure/RNAClean XP beads (Beckman Coulter) per 1 µl of sample were used during all the 
purification steps including the library clean up. Other steps were performed as described in the 
protocol (Herman et al., 2018). Libraries were sequenced on an Illumina HiSeq 3000 sequencing 
system (pair-end multiplexing run, high output mode) at a depth of ~200,000 reads per cell. 
Bioinformatic analyses 
Raw sequencing data for both single cell and bulk experiments were controlled for quality, trimmed 
and mapped to the reference mm10 genome using STAR (Dobin et al., 2013). The identity of reads 
 was identified through FeatureCount (Liao et al., 2014). For scRNA-seq analyses, the RNA expression 
matrices from each cell were merged and further analysed with the RaceID3 software package 
(Herman et al., 2018). Cells with less than 1500 unique transcripts were discarded, which left 625 cells 
for downstream analysis. For downstream analyses, ribosomal genes as well as the highly expressed 
ncRNA Malat1 were removed. Cells were clustered using k-medoids and the clustering result was 
confirmed using the random forest algorithm within the RaceID3 package. Clusters from the scRNA-
seq data were visualized through the two-dimension t-distributed stochastic neighbour embedding 
(tSNE) algorithm within the RaceID3 package. For both scRNA-seq and the bulk RNA-seq analyses, 
differentially expressed genes between the cell types or cell clusters were identified using DESeq2 
(Love et al., 2014). 
Inter-cellular ligand-receptor interaction networks were calculated based on the publically available 
database collated by Ramilowski and co-workers (Ramilowski et al., 2015). Mouse orthologs of human 
genes were obtained using the biomaRt R package (Durinck et al., 2005; Durinck et al., 2009). The 
connection between cell type and itself (autocrine) or another cell type (paracrine) was established if 
the receptor and its associated ligand were expressed in at least one of the four cell types. The ligand 
or receptor was considered expressed in each scRNA-seq cluster if the mean expression per cluster 
was higher than 0.7 normalised transcripts. In contrast, the ligand or receptor was considered 
expressed in the bulk RNA-seq dataset if the mean expression per cell type was higher than 10 
FPKM, and the respective ligand or receptor expression in the given cell type was higher than 10% of 
maximal expression of the given ligand/receptor in any cell type. Directionality of a given interaction 
was determined by the cell type expressing the ligand. Colours in Figures 4B and S3B correspond to 
the cell type or cluster expressing the ligand, while the thickness of the lines is proportional to the 
number of interaction pairs between cell types. For visualization of interaction networks, the igraph 
(Csardi and Nepusz, 2006) and iTALK (Wang et al., 2019) R packages were utilized. The network of 
top 50 enriched interactions was generated with the additional criterion for the ligands to be enriched 
with an enrichment score > 0.5 in a cell type. For ranking the ligand-receptor interactions, the absolute 
expression (FPKM) of both the ligand and receptor in each interacting pair was taken into account. 
The enrichment score was calculated for each gene based on the normalized DESeq2 gene 
expression matrix; Mean expression of a gene across all cell types was subtracted from the 
expression levels of that gene in a particular cell type, and subsequently divided by the standard 
deviation. Thus, the enrichment score for a particular gene in a cell type represents the number of 
standard deviations from its mean expression across all analysed cell types.  
 
Generation of the Brain Interactome Explorer website 
The R code for generating circos plots from normalized expression values was wrapped in a shiny app 
using CRAN R package shiny version 1.3.2 (Chang et al., 2019) and R version 3.6. The resulting 
shiny app 'Brain Interactome Explorer' version 1.0.0 is served on shinyapps.io under https://mpi-
ie.shinyapps.io/braininteractomeexplorer/. The R code underlying the app is available 
under https://github.com/maxplanck-ie/BrainInteractomeExplorer. 
  
Immunofluorescence  
Testing of vascular PECAM1, ICAM2, PDGFRβ and NG2 antibodies 
Brains were isolated from E14.5 embryos, meninges removed and both cortices isolated. The 
dissected cortices were fixed in 4% paraformaldehyde at room temperature for 30 minutes. After brief 
washing, samples were stored in 100% methanol at 4°C. For staining, the cortices were washed in 50% 
methanol for 10 minutes, once in PBS for 10 minutes and twice in wash buffer (0.1% Triton X-100 in 
PBS) for 15 minutes each. Samples were blocked in 10% fetal calf serum (FCS) for 1 hour at room 
temperature and then incubated with primary antibodies raised against PDGFRβ and PECAM1 (CD31, 
(1:50), diluted in wash buffer supplemented with 10% FCS, overnight at 4°C. The cortices were 
subsequently processed through the wash buffer three times (10 minutes each) at 4°C and then three 
times at room temperature. The cortices were incubated with secondary antibodies (Donkey anti-goat 
Alexa488, A21206, 1:400; donkey anti-rabbit Alexa555, A31572, 1:400) diluted in FACS buffer and 
incubated at room temperature for 2 hours. The samples were then washed three times at 4°C for 10 
minutes each and subsequently three times for 1 hour at room temperature. The cortices were 
subsequently stained with DAPI (1:1000 diluted in PBS) for 30 minutes at room temperature and 
washed three times for 10 minutes each. The stained cortices were flattened, mounted in Fluoromount 
and imaged using the LSM780 microscope from Zeiss using the 63x oil objective. Data were 
processed using the Zen Blue software (Zeiss). 
Immunofluorescence analyses of overlap in protein localisation 
Freshly dissected E14.5 brains were fixed in 4% paraformaldehyde at room temperature for 2 hours, 
washed with PBS and embedded in a 25% albumin; 6% gelatine solution. Embedded samples were 
fixed further in 4% paraformaldehyde overnight, washed and subsequently stored in PBS until 
sectioning. Approximately 100 µm thick sections were cut on a vibratome and slices were released in 
PBS. Each section was transferred to a well of a 24-well plate for subsequent staining. For stainings 
with antibodies against IBA1, APOE, LDLR, LRP1 and βIII-tubulin, sections were permeabilized and 
blocked in PBS containing 0.5% TritonX-100 and 0.25% gelatine overnight at 4°C and all antibody 
incubations were carried out in PBS supplemented with 0.25% gelatine. For stainings with antibodies 
raised against VTN, KDR, PECAM1, LAMA4 and ITGB1, sections were permeabilised and blocked in 
PBS containing 0.5% Triton X-100 and 10% FCS overnight at 4°C. All samples were incubated with 
the respective combinations of primary antibodies (1:200) overnight at 4°C, washed four times for 30 
minutes each at room temperature, and incubated with the appropriate secondary antibodies (donkey 
anti-goat 594 (1:250, Life Technologies #A11058), donkey anti-rabbit 488 (1:250, Life Technologies 
#A11055), goat anti-mouse 594 (1:250, Life Technologies #A11032), donkey anti-rabbit 555 (1:250, 
Life Technologies #A31572), goat anti-mouse 488 (1:250, Life Technologies #A11001)) overnight at 
4°C.  After a further 4 washes in PBS, samples were stained with DAPI (1:250, 20 minutes, RT), 
mounted onto slides with Fluoromount and imaged using the Zeiss Airyscan LSM 880 microscope with 
the 25x oil objective. Data were processed using the Zen Blue software (Zeiss). 
  
Co-immunoprecipitation assays  
Cell lysates were prepared in HMG150 buffer (25 mM HEPES pH 7.6, 12.5 mM MgCl2, 10% glycerol, 
150 mM KCl, 0.5% Tween-20 and Protease Inhibitor Complete Mini (Roche #04693159001)) from wild 
type snap frozen E14.5 brains and 250 µg of protein were used for each IP. A mixture of Protein A/G 
beads (Sepharose 4 Fast Flow Protein G (GE Healthcare #17-0618-05) and Protein A (GE Healthcare 
#17-5280-02)) were blocked by incubating with 0.2 mg/ml BSA in HMG150 for 30 minutes at 4°C. 
After pre-clearing brain lysates with 100 µl of a Protein A/G beads-slurry, 5 µg of the anti-APOE 
antibody were added and samples incubated overnight at 4°C. IPs with rabbit IgG (Rb-IgG, Abcam 
#ab172730) were used as controls. Next, 100 µl of blocked Protein A/G beads-slurry were added, 
samples incubated at 4°C for 1 hour and washed 3 times in HMG150 for 10 minutes each. 
Immunoprecipitated protein was eluted in ROTI-load (Roth #K929.1), boiled briefly and run on a 4-12% 
gradient gel (NuPAGE, Life Technologies #NP0321Box). Following transfer onto 0.45 µm PVDF 
membranes (ImmobilonP Membrane, Millipore #IPVH00010), membranes were blocked in 5% skim 
milk, incubated overnight at 4°C with antibodies raised against APOE and LRP1 (1:1000). After 
washing, the membranes were incubated with the HRP-conjugated anti-rabbit or anti-goat antibodies 
(ECL anti-rabbit HRP, GE Healthcare #NA934 and ECL anti-goat HRP, Santa Cruz #sc2354) for 1 
hour at room temperature, washed and developed on the Chemi Doc System (Biorad), using the Lumi-
Light reagent (Lumi Light Plus Western Blotting Substrate, Roche #12015196001). 
 
Data and software availability 
The Brain Interactome Explorer is available at https://mpi-ie.shinyapps.io/braininteractomeexplorer/. 
Raw sequencing data have been uploaded to GEO and are available under GSE133079. 
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